{"Title": ["HZNP Crosses Above Average Analyst Target", "Horizon Therapeutics PLC (HZNP) Q1 2020 Earnings Call Transcript", "Health Care Sector Update for 05/06/2020: SDC,AET,UNH,HZNP,TGTX,SILK", "Health Care Sector Update for 05/06/2020: HZNP,TGTX,SILK", "Why Horizon Therapeutics Is Soaring Today", "Stock Alert: Horizon Therapeutics Up 9%", "First Week of June 19th Options Trading For Horizon Therapeutics (HZNP)", "Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?", "HZNP Crosses Above Average Analyst Target", "Buy This 1 Pharma Stock to Outperform the Bear Market", "HZNP Makes Notable Cross Below Critical Moving Average", "Horizon Therapeutics PLC (HZNP) Q4 2019 Earnings Call Transcript", "Horizon Therapeutics PLC (HZNP) Q4 2019 Earnings Call Transcript", "Horizon Therapeutics Reports Q4 Results, Beats Revenue Target", "Stock Alert: Horizon Therapeutics (HZNP)", "Horizon Therapeutics Gets FDA Approval for Eye Drug", "Should You Buy These 3 Biotechs Now?", "First Drug For TED Secures Approval, TROV On Watch, EVOK Faces FDA In June", "FDA Approves First-Ever Treatment for Thyroid Eye Disease", "3 Healthcare Stocks Primed for 2020 Gains", "First Week of August 2020 Options Trading For Horizon Therapeutics (HZNP)", "Horizon Therapeutics Rally May Be Short-Lived As Investors Wait For Key Date In March", "4 Healthcare Stocks With FDA Approvals on the Horizon", "S&P 500: Winning Streak Ends", "First Week of HZNP March 20th Options Trading", "First Drug For TED Secures Approval, TROV On Watch, EVOK Faces FDA In June", "Healthcare Stocks That Hit New Highs ( RETA, FLGT, HZNP,...)", "Healthcare Stocks That Hit New Highs ( GSK, NVO, NVST,...)", "Horizon Pharma PLC (HZNP) Q2 2019 Earnings Call Transcript", "HZNP Crosses Below Key Moving Average Level", "First Week of HZNP September 20th Options Trading", "BMY To Explore Stivarga/Opdivo Combo, MYOK Ahead Of Timeline, UNH On Watch", "3 Market-Beating Stocks for Your 2020 Radar", "Relative Strength Alert For Horizon Pharma", "Recordati to seek Canadian approval for kidney disease drug", "The Implied Analyst 12-Month Target For GURU", "Health Care Sector Update for 03/06/2019: HZNP,INFI,HCR,VSTM,SRPT,LGND,NVS", "3 High-Growth Stocks That Are Just Getting Started", "Company News For Mar 1, 2019", "Why These Pharma ETFs Rallied on Thursday", "Commit To Buy Horizon Therapeutics At $15, Earn 9% Using Options", "3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation", "Mid-Day Market Update: Veritiv Falls After Q4 Results; Horizon Pharma Shares Surge", "Why Horizon Pharma Is Surging Today", "Horizon Pharma's (HZNP) Stock Up on Q4 Earnings & Sales Beat", "Mid-Morning Market Update: Markets Open Lower; J C Penney Profit Beats Expectations", "Why Monster Beverage, Horizon Pharma, and Guardant Health Jumped Today", "Mid-Afternoon Market Update: Box Drops On Weak Forecast; Arcadia Biosciences Shares Gain", "Horizon Pharma Reaches Analyst Target Price", "3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation", "Health Care Sector Update for 02/05/2019: MRNA,ARRY,HZNP,HAE", "Health Care Sector Update for 02/05/2019: ARRY,HZNP,HAE", "HZNP April 18th Options Begin Trading", "Do Options Traders Know Something About Horizon Pharma (HZNP) Stock We Don't?", "Horizon Pharma (HZNP) Up 28% on Business Expansion Strategy", "3 Top Mid-Cap Stocks to Buy Right Now", "Horizon Pharma PLC (HZNP) Q4 2018 Earnings Conference Call Transcript", "Horizon Pharma (HZNP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "Health Care Sector Update for 02/05/2019: MRNA,ARRY,HZNP,HAE", "Health Care Sector Update for 02/05/2019: ARRY,HZNP,HAE", "HZNP April 18th Options Begin Trading", "Horizon Pharma (HZNP) Tops Q3 Earnings and Revenue Estimates", "Earnings Reaction History: Horizon Pharma Inc, 63.6% Follow-Through Indicator, 9.1% Sensitive", "Horizon Pharma's Ravicti Gets FDA Nod for Expanded Age Group", "HZNP December 2020 Options Begin Trading", "Horizon Pharma (HZNP) Down 1.9% Since Last Earnings Report: Can It Rebound?", "Horizon Pharma Completes Enrollment in Eye Disease Study", "First Week of October 19th Options Trading For Horizon Pharma (HZNP)", "These 3 Value Stocks Are Absurdly Cheap Right Now", "Horizon Pharma (HZNP) Boasts Robust Pipeline Amid Competition", "Is A Disappointment in Store for Tilray (TLRY) Q3 Earnings?", "Endo (ENDP) to Report Q3 Earnings: What's in the Cards?", "Horizon Pharma (HZNP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "Horizon Pharma (HZNP) Down 1.9% Since Last Earnings Report: Can It Rebound?", "Horizon Pharma Completes Enrollment in Eye Disease Study", "Is a Beat in Store for Horizon Pharma (HZNP) in Q2 Earnings?", "Is a Beat in Store for BioDelivery (BDSI) in Q2 Earnings?", "Is a Beat in the Cards for Nektar (NKTR) in Q2 Earnings?", "HZNP Crosses Above Average Analyst Target", "What's in the Cards for Arena (ARNA) This Earnings Season?", "What's in Store for ImmunoGen (IMGN) This Earnings Season?", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "Is a Beat in Store for Bristol-Myers (BMY) in Q2 Earnings?", "7 Healthcare Stocks That Are Coming to Life", "10 Underappreciated Biotech Stocks to Buy", "Implied IYH Analyst Target Price: $205", "What Lies in Store for Ligand (LGND) This Earnings Season?", "Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up", "Horizon Pharma (HZNP) Q1 Earnings & Sales Miss, Shares Fall", "HZNP Makes Notable Cross Below Critical Moving Average", "Health Care Sector Update for 05/09/2018: HZNP, MYL, LPCN, ARGX", "Horizon Pharma (HZNP) Q1 Loss Wider, Revenues Miss", "Health Care Sector Update for 05/09/2018: HZNP,MYL,LPCN", "Interesting HZNP Put And Call Options For November 16th", "Why Is Horizon Pharma (HZNP) Up 18.3% Since Its Last Earnings Report?", "Zacks.com highlights: Western Digital, Daqo New Energy, Horizon Pharma Public and American Axle & Manufacturing Holdings", "4 Low P/CF Stocks Ready to Add Value to Your Investment", "Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% Higher", "Zacks.com highlights: Western Digital, ArcelorMittal, Arrow Electronics and Horizon Pharma Public", "Enhance Your Portfolio With These 5 Low Price-to-Book Stocks", "Pick These 4 Low P/CF Stocks & Sail Through a Volatile Market", "Commit To Buy Horizon Pharma At $10, Earn 11% Using Options", "What's in Store for Horizon Pharma (HZNP) in Q1 Earnings?", "Zacks.com highlights: Western Digital, Daqo New Energy, Horizon Pharma Public and American Axle & Manufacturing Holdings", "4 Low P/CF Stocks Ready to Add Value to Your Investment", "Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% Higher", "Zacks.com highlights: Western Digital, ArcelorMittal, Arrow Electronics and Horizon Pharma Public", "Enhance Your Portfolio With These 5 Low Price-to-Book Stocks", "Pick These 4 Low P/CF Stocks & Sail Through a Volatile Market", "Pfizer's Chantix Fails in Phase IV Study in Young Smokers", "4 Drug/Biotech Stocks to Buy Ahead of World Health Day", "Conatus' Emricasan Fails in Phase II Study, Shares Sink", "Pick These 5 Winning Stocks Based on a Favorable P/B Ratio", "Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease", "Horizon Pharma (HZNP) Down 3.9% Since Earnings Report: Can It Rebound?", "5 Valuable Price-to-Book Stocks to Boost Your Portfolio", "Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up", "Clovis Gets Positive CHMP Opinion for Ovarian Cancer Drug", "5 Discounted PEG Stocks for Value Investors", "Sarepta to Seek Rapid Approval for Second DMD Drug, Stock Up", "Zacks.com highlights: TheStreet, Barclays, Horizon Pharma, Regions Financial and TechTarget", "5 Cheap Breakout Stocks for Explosive Returns", "5 Low Price-to-Book Stocks With Great Growth Prospects", "Horizon Pharma (HZNP) Tops Q4 Earnings, Provides 2018 View", "Horizon Pharma (HZNP) Tops Q4 Earnings, Revenues Beat", "Is Horizon Pharma Public (HZNP) a Great Stock for Value Investors Right Now?", "5 Discounted PEG Stocks for Value Investors", "Interesting HZNP Put And Call Options For March 16th", "Commit To Buy Horizon Pharma At $10, Earn 11.5% Using Options", "Noteworthy Wednesday Option Activity: WDFC, KSU, HZNP", "3 Top Value Stocks to Buy in 2018", "Horizon Pharma Gets FDA Nod for Procysbi Label Expansion", "Horizon Pharma Shows Improved Relative Price Performance; Still Shy Of Benchmark", "Earnings Reaction History: Horizon Pharma Inc, 63.6% Follow-Through Indicator, 10.8% Sensitive", "Depomed Executes an Exit Strategy for Its Opioid Drug", "Horizon Pharma (HZNP) Tops Q3 Earnings & Sales, Ups View", "Horizon (HZNP) Tops Q3 Earnings, Shares Up", "Earnings Reaction History: Horizon Pharma Inc, 72.7% Follow-Through Indicator, 11.5% Sensitive", "Key Predictions for Q3 Earnings Reports of MYL, HZNP & KERX", "Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store? (revised)", "Stocks With Rising Relative Price Strength: Horizon Pharma", "Horizon Pharma Earns RS Rating Upgrade", "Depomed Executes an Exit Strategy for Its Opioid Drug", "Horizon Pharma (HZNP) Tops Q3 Earnings & Sales, Ups View", "Horizon (HZNP) Tops Q3 Earnings, Shares Up", "Earnings Reaction History: Horizon Pharma Inc, 72.7% Follow-Through Indicator, 11.5% Sensitive", "Key Predictions for Q3 Earnings Reports of MYL, HZNP & KERX", "GURU's Holdings Imply 10% Gain Potential", "Horizon Pharma (HZNP) Q3 Earnings: A Disappointment in Store?", "10 Zombie Stocks to Buy Before They Return From the Grave", "Commit To Buy Horizon Pharma At $10, Earn 12% Using Options", "Horizon Pharma PLC (HZNP) Q2 Report Sends Shares Surging", "Dow To Continue Rally?", "Can the Dow Go for 10 Straight?", "Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session", "IYH's Underlying Holdings Imply 10% Gain Potential", "Horizon Pharma (HZNP) Tops Earnings in Q2, Shares Up", "Earnings Reaction History: Horizon Pharma Inc, 81.8% Follow-Through Indicator, 11.2% Sensitive", "Pre-Market Earnings Report for August 7, 2017 : TSN, FDC, ON, BAH, DCP, GEO, KOS, IIVI, HAE, FOLD, HZNP, FI", "Can Horizon Pharma (HZNP) Spring a Surprise in Q2 Earnings?", "Commit To Buy Horizon Pharma At $8, Earn 11.2% Using Options", "Health Care Sector Update for 06/27/2017: JNJ, PFE, ABT, MRK, AMGN, ARLZ, ESPR, SNY", "Why Horizon Pharma plc Stock Is Rising Today", "Horizon Pharma Gets Health Canada Approval for Procysbi", "Horizon Pharma (HZNP) Up 11.3% Since Earnings Report: Can It Continue?", "3 Value Stocks You Probably Haven't Considered", "Falling Earnings Estimates Signal Weakness Ahead for Horizon Pharma (HZNP)", "Horizon Pharma Enters Oversold Territory (HZNP)", "Horizon (HZNP) Sells European Rights for Procysbi & Quinsair", "Horizon (HZNP) Falls on Q1 Earnings Miss, Guidance Trimmed", "3 Cheap Healthcare Stocks You Can Buy Right Now", "Pre-Market Most Active for May 8, 2017 : KATE, HZNP, JD, LYG, IBN, PSO, BCS, DB, MU, AAPL, CTSH, TVIX", "Earnings Reaction History: Horizon Pharma Inc, 80.0% Follow-Through Indicator, 7.5% Sensitive", "Why Liberty Global, Horizon Pharma, and Synchronoss Technologies Slumped Today", "Health Care Sector Update for 05/08/2017: KITE,HZNP,NVS,HZNP", "Here's Why Shares of Horizon Pharma (HZNP) are Cratering Today", "Notable Monday Option Activity: OPK, HTZ, HZNP", "Why Horizon Pharma plc Stock Is Crashing Today", "Horizon Pharma (HZNP) Misses Q1 Earnings, Shares Crash", "Mylan (MYL) Q1 Earnings: Will the Stock Pull a Surprise?", "Is Horizon Pharma (HZNP) Poised for a Beat in Q1 Earnings?", "Implied FTXH Analyst Target Price: $24", "What's in Store for Mallinckrodt (MNK) This Earnings Season?", "The 7 Most Expensive Prescription Drugs in the World", "Commit To Buy Horizon Pharma At $10, Earn 7.6% Annualized Using Options", "Horizon (HZNP) Down 10.2% Since Earnings Report: Can It Rebound?", "Should You Buy Horizon Pharma PLC (HZNP) Ahead of Earnings?", "Earnings Reaction History: Horizon Pharma Inc, 63.6% Follow-Through Indicator, 7.4% Sensitive", "Why Tesla, AmTrust Financial Services, and Horizon Pharma Slumped Today", "Horizon Pharma (HZNP) Misses Q4 Earnings & Revenues", "Noteworthy Friday Option Activity: AXDX, AAOI, HZNP", "Pre-Market Earnings Report for February 27, 2017 : AMT, FMX, AES, TGNA, SNH, AFSI, TCP, HZNP, NGHC, KOS, AWI, BID", "Horizon (HZNP) Q4 Earnings: Stock Likely to Disappoint?", "Can Horizon Pharma (HZNP) Be a Great Stock for Value Investors?", "3 Beaten Biotech Stocks That Are Set to Rebound", "XPH, JAZZ, LLY, HZNP: Large Outflows Detected at ETF", "Notable Friday Option Activity: MIC, MSFT, HZNP", "Sum Up The Parts: GURU Could Be Worth $27", "Commit To Purchase Horizon Pharma At $13, Earn 15.9% Annualized Using Options", "Horizon's Rare Disease Drug Quinsair Launched in Canada", "Here's Why Horizon Pharma Stock Jumped As Much As 16.8% Today", "3 Companies That Need to Kick Their CEO to the Curb", "Horizon (HZNP) Stock Sinks, Friedreich's Ataxia Study Fails", "HZNP Crosses Below Key Moving Average Level", "Horizon Pharma PLC (HZNP) Stock Plunges on Drug Trial Failure", "Wall Street Sees Steady Open as ECB Leaves Rates Unchanged, US Jobless Claims Decline", "Pre-Market Most Active for Dec 8, 2016 : HZNP, BAC, DB, AZN, GFI, CS, BCS, TLT, XIV, LULU, QQQ, TVIX", "U.S. Futures Tread Water as European Central Bank Keeps Rates Unchanged", "Why Las Vegas Sands, Horizon Pharma, and IDT Slumped Today", "Pre-Market Most Active for Dec 16, 2016 : SAN, GPOR, BAC, AZN, HZNP, DCIX, TLT, CHK, TIG, SYT, SDRL, QQQ", "Horizon (HZNP) Stock Sinks, Friedreich's Ataxia Study Fails", "HZNP Crosses Below Key Moving Average Level", "Horizon Pharma PLC (HZNP) Stock Plunges on Drug Trial Failure", "Horizon (HZNP) Stock Up Despite Q3 Earnings, Revenue Miss", "If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys", "Horizon (HZNP) Misses Q3 Earnings, Revenue Estimates", "Health Care Sector Update for 11/07/2016: HZNP, VRTX", "Top Research Reports for 29th November, 2016", "Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday", "Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More", "Horizon (HZNP) Q3 Earnings Preview: Stock to Disappoint?", "Analysts Forecast 10% Upside For FNX", "Horizon (HZNP) Stock Down on Dull Q3 View; Cuts '16 Outlook", "Alcoa Inc (AA) Stock Punished After Third-Quarter Earnings Miss", "Horizon Pharma, Express Scripts to Settle Rebate Litigation", "Earnings Reaction History: Horizon Pharma Inc, 60.0% Follow-Through Indicator, 8.8% Sensitive", "Why Horizon Pharma PLC Jumped Higher Today", "Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More", "Horizon (HZNP) Q3 Earnings Preview: Stock to Disappoint?", "Analysts Forecast 10% Upside For FNX", "Inside the Recent Surge in Biotech ETFs", "Company News for September 13, 2016", "Kite, Anavex, G.W. Pharma Help Revive Biotech Sector Chemistry", "Commit To Purchase Horizon Pharma At $10, Earn 14% Using Options", "HZNP, RPTP: Horizon Pharma PLC Stock Jumps on $800 Million Raptor Pharmaceutical Corp. Buy", "Horizon Pharma's Pivot Continues With $800 Million Buyout of Raptor Pharmaceuticals", "Forget the S&P 500, Buy These 3 High Growth Healthcare Stocks Instead", "Why Raptor Pharmaceuticals, OpenText, and Freeport-McMoRan Jumped Today", "Close Update: Stocks Rally as Fed Governor Brainard Urges Caution on Rate Increases", "Health Care Sector Update for 09/12/2016: PRGO,RPTP,HZNP,CYDY", "Horizon (HZNP) to Acquire Raptor for $800M, Stock Soars", "Mylan's EpiPen Misclassified, Rebates Underpaid; Stock Down", "HZNP Crosses Below Key Moving Average Level", "Horizon (HZNP) Rayos Receives USPTO Notice of Allowance", "Analysts See 12% Gains Ahead For The Holdings of IYH", "Top-Rated Stock Picks and Popular Stories on Nasdaq.com: August 7 - 13", "5 Low Price-to-Book Stocks That Can Prove Valuable", "Tuesday's ETF with Unusual Volume: VTWO", "Health Care Sector Update for 09/12/2016: GERN, JNJ, RPTP", "Mylan's EpiPen Misclassified, Rebates Underpaid; Stock Down", "HZNP Crosses Below Key Moving Average Level", "Horizon (HZNP) Rayos Receives USPTO Notice of Allowance", "Analysts See 12% Gains Ahead For The Holdings of IYH", "Top-Rated Stock Picks and Popular Stories on Nasdaq.com: August 7 - 13", "5 Low Price-to-Book Stocks That Can Prove Valuable", "Can Horizon (HZNP) Surprise Earnings Estimates in Q2?", "Horizon (HZNP) Earnings Up Y/Y, Keeps '16 View, Stock Up", "Horizon Pharma PLC: HZNP Stock Pops After HUGE Earnings Beat", "Noteworthy ETF Outflows: XPH, MNK, AKRX, HZNP", "Looking for Bargain Stocks? Pick These 5 with Low P/B Ratio", "HZNP Makes Bullish Cross Above Critical Moving Average", "Commit To Buy Horizon Pharma At $10, Earn 22% Using Options", "Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing", "Wednesday's ETF Movers: IHE, XLU", "Pre-Market Most Active for Aug 2, 2016 : BRX, RDS/B, DRUA, ARMH, IDTI, NYRT, FTR, CS, CUK, HZNP, QQQ, XIV", "Health Care Sector Update for 06/01/2016: HZNP, TBPH", "Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well", "Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down", "Horizon (HZNP) Stock Up Despite Earnings & Revenue Miss", "The Zacks Analyst Blog Highlights: Horizon Pharma, Incyte, Juno Therapeutics, Halozyme Therapeutics and Kite Pharma", "Horizon (HZNP) Misses Q1 Earnings and Revenue Estimates", "Earnings Reaction History: Horizon Pharma Inc, 60.0% Follow-Through Indicator, 8.0% Sensitive", "Is Horizon Pharma's Rebound Sustainable?", "Health Care Sector Update for 05/09/2016: HZNP,DEPO,EGRX,UNIS", "Here's Why Horizon Pharma plc's Stock Slumped in April", "Health Care Sector Update for 05/05/2016: HZNP, KMPH", "What Caused DepoMed's Shares to Skyrocket 20.9% In April", "What's in Store for Horizon (HZNP) This Earnings Season?", "5 Stock Buys with Impressive Price-to-Cash Flow Ratios", "Friday's ETF with Unusual Volume: IYH", "Close Update: Wall Street Posts Mixed Close as Oil Weighs on Dow and Health Boosts Nasdaq", "Health Care Sector Update for 05/09/2016: HZNP,DEPO,EGRX,UNIS", "Here's Why Horizon Pharma plc's Stock Slumped in April", "Biotech Stock Roundup: FDA Advisory Panels Say Yes to Intercept, No to Clovis", "Why Horizon Pharma, Och-Ziff Capital Management, and Clovis Oncology Slumped Today", "Why One Activist Thinks This Company Is Too Cheap", "Why Horizon Pharma Shares Sank Today", "Why is Horizon Pharma (HZNP) Crashing Today?", "The Zacks Analyst Blog Highlights: Intercept, Clovis, AbbVie, Relypsa and Horizon Pharma", "Horizon Pharma Plunges on Bleak Q1 and 1H16 Guidance", "Vanguard Total Stock Market ETF Experiences Big Inflow", "Depomed Inc (DEPO) Stock Soars on Starboard Stake", "Will Horizon Pharma (HZNP) Continue to Surge Higher?", "4 Top Ranked Healthcare Stocks that Surged Last Session", "Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know", "The Zacks Analyst Blog Highlights: Edwards Lifesciences, PRA Health Sciences, Gilead Sciences, AMAG Pharmaceuticals and Horizon Pharma", "Tuesday's ETF Movers: XOP, XPH", "3 Biotech Stocks That Make the Grade for Investors", "If It Wasn't For Pfizer, Allergan Investors Might Be Getting Pummeled", "Why Valeant Pharmaceuticals' Stock Rose 10% on Tuesday", "7 Best Stocks Under $20 that Can Fetch Solid Returns", "This Week's Top Value Picks: (HZNP)(CIB)(GXG)", "Eagle Pharmaceuticals Down on CRL for Kangio from FDA", "Celgene & Pfizer Present Data from Ulcerative Colitis Trials", "VTI, VIS, HZNP, BXMT: ETF Inflow Alert", "3 Biotech Stocks That Make the Grade for Investors", "If It Wasn't For Pfizer, Allergan Investors Might Be Getting Pummeled", "Why Valeant Pharmaceuticals' Stock Rose 10% on Tuesday", "7 Best Stocks Under $20 that Can Fetch Solid Returns", "Julian Robertson Buys 8 New Stakes in 4th Quarter", "Theravance (TBPH) Posts Narrower-than-Expected Q4 Loss", "Aduro BioTech (ADRO) Reports Q4 Earnings, Revenue Up", "VTI, VIS, HZNP, BXMT: ETF Inflow Alert", "Sanofi, Merck to Dissolve Joint Vaccines Venture in Europe", "Sanofi/Genzyme Present Positive Pompe Disease Study Data", "AstraZeneca's Faslodex Gains FDA Nod for Label Expansion", "Amgen Seeks FDA Approval for Blincyto's Label Expansion", "Company News for March 01, 2016", "Juno (JUNO) Posts In-Line Loss in Q4, Focus on Pipeline", "Horizon (HZNP) Misses on Q4 Earnings, Beats on Revenues", "Merck KGaA's Q4 Earnings Down Y/Y, Offers 2016 Outlook", "Intrexon (XON) Reports Wider Q4 Loss, Beats on Revenues", "Puma (PBYI) Reports In Line Q4 Loss, Neratinib in Focus", "Why Horizon Pharma PLC Shares Are Crashing Today", "Horizon Pharma Misses on Q4 Earnings, Beats on Revenues", "Pre-Market Most Active for Feb 29, 2016 : SUNE, TVIX, VRX, FDML, BAC, ING, NOK, TLK, HZNP, XIV, QQQ, GRPN", "Earnings Reaction History: Horizon Pharma Inc, 45.5% Follow-Through Indicator, 7.1% Sensitive", "Endo (ENDP) Tops Q4 Earnings Estimates, Gives 2016 Outlook", "Kite Pharma Q4 Loss Wider but Focus Remains on KTE-C19", "Pre-Market Earnings Report for February 29, 2016 : VRX, ENDP, IEP, NRG, HZNP, TRCO, VGR, ACAD, GRFS, BCPC, FI, SJI", "Is Horizon (HZNP) Set to Disappoint this Earnings Season?", "Jazz Tops Q4 Earnings, Revenues Up Y/Y, Gives 2016 View", "PDL BioPharma Beats on Q4 Earnings, Revenues Up Y/Y", "Infinity (INFI) Q4 Loss Narrower than Expected, Revenues Lag", "ARIAD Incurs Wider-than-Expected Loss in Q4, Shares Down", "The Zacks Analyst Blog Highlights: Horizon Pharma, ING Groep N.V., AstraZeneca and Mallinckrodt", "Sarepta's Q4 Loss Wider than Expected, Eteplirsen in Focus", "Pre-Market Earnings Report for February 29, 2016 : VRX, ENDP, IEP, NRG, HZNP, TRCO, VGR, ACAD, GRFS, BCPC, FI, SJI", "Is Horizon (HZNP) Set to Disappoint this Earnings Season?", "Jazz Tops Q4 Earnings, Revenues Up Y/Y, Gives 2016 View", "PDL BioPharma Beats on Q4 Earnings, Revenues Up Y/Y", "Infinity (INFI) Q4 Loss Narrower than Expected, Revenues Lag", "ARIAD Incurs Wider-than-Expected Loss in Q4, Shares Down", "The Zacks Analyst Blog Highlights: Horizon Pharma, ING Groep N.V., AstraZeneca and Mallinckrodt", "4 Stocks to Help Combat Brexit Fears", "Repros, FDA Meet to Discuss Issues of Enclomiphene's CRL", "Amgen's Blincyto and Repatha Positive in Phase III Studies", "AstraZeneca Tops Q4 Earnings, Falls on Bleak 2016 Outlook", "Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact", "Sanofi Begins Search for Vaccine for Zika Virus as Fear Grows", "AstraZeneca's Lynparza Gets Breakthrough Therapy Status", "Alkermes Initiates Early-Stage Study on Alzheimer's Drug", "Cytori Tanks on Unfavorable Data from Osteoarthritis Study", "The Zacks Analyst Blog Highlights: Gilead Sciences, Horizon Pharma, NXP Semiconductor and TDK", "Oil Short Covering Isn't A Share Price Bottom - Global Week Ahead", "The Zacks Analyst Blog Highlights: Horizon Pharma, Axiall, Trina Solar, Deep Value ETF and PowerShares High Yield Equity Dividend Achievers Portfolio", "Amgen Presents Encouraging Phase III Data on Vectibix", "Stocks & ETFs Below $20 for High Returns", "Alkermes Hit 52-Week Low on Unfavorable Phase III Data", "Zafgen Soars on Positive Phase III Efficacy Data on Beloranib", "3 Reasons Horizon Pharma plc's Stock Could Fall", "The Zacks Analyst Blog Highlights: Gilead Sciences, Horizon Pharma, NXP Semiconductor and TDK", "Oil Short Covering Isn't A Share Price Bottom - Global Week Ahead", "The Zacks Analyst Blog Highlights: Horizon Pharma, Axiall, Trina Solar, Deep Value ETF and PowerShares High Yield Equity Dividend Achievers Portfolio", "The Zacks Analyst Blog Highlights: Baxalta, Juno, Horizon Pharma, AbbVie and Dynavax", "Health Care Sector Update for 01/14/2016: HZNP, KPTI", "Esperion (ESPR) Initiates Phase III Study for Hyperlipidemia", "Galapagos (GLPG) Gives Update on Cystic Fibrosis Program", "Gilead Seeks Approval for Tenofovir Alafenamide for HBV", "Horizon (HZNP) Ups View on Crealta Holdings Deal, Shares Up", "The Zacks Analyst Blog Highlights: Aegean Marine Petroleum Network, Danaos, Tsakos Energy Navigation, Horizon Pharma and ICON Public Limited", "Alnylam Provides Update on RNAi Therapeutics Pipeline", "Biotech Stock Roundup: Baxalta - Shire to Combine, JPM Healthcare Conference in Focus", "Incyte (INCY) Provides Update on Pipeline Candidates", "The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceuticals and Inovio Pharmaceuticals", "Instant Analysis: Horizon Pharma Raises 2016 Sales, Profit Guidance", "BioMarin Reveals Interim Data from Pompe Disease Study", "5 Smart PIIGS Stocks to Buy Now", "AbbVie Starts Phase III Program on ABT-494 for RA Treatment", "AbbVie's Viekira Pak sNDA Accepted with Priority Review", "Vical's VL-2397 Gets Orphan Status for Invasive Aspergillosis", "Peregrine (PPHM) Inks Research Partnership for Bavituximab", "Conatus (CNAT) Reports Positive Phase II Data on Emricasan", "SurModics Buys NorMedix for $14M, Adjusts 2016 Outlook", "Gilead Up on Encouraging Data on Tenofovir Alafenamide", "Teva/Active Biotech Halt High Doses of Laquinimod for MS", "Pfizer & Merck KGaA Partner with Syndax for Ovarian Cancer", "These 3 Industries Could Die in 2016", "Bristol-Myers' Opdivo/Yervoy sBLA to Face Final Decision", "Alkermes Upgraded to Hold on Encouraging Portfolio Update", "Epizyme Initiates Dosing in Phase II Study on Tazemetostat", "Why Horizon Pharma plc Shares Jumped 68% in 2015", "Discovery Laboratories Advances Respiratory Disease Drug", "Anika (ANIK) Starts Enrolment in Phase III HyaloFast Study", "Chimerix (CMRX) Tanks on Disappointing Brincidofovir Data", "Kamada (KMDA) Reports Encouraging Data on Rabies Drug", "This Week's Top Value Stocks: (HZNP) (DF)", "GW Pharmaceuticals Publishes Encouraging Epidiolex Data", "Adamas (ADMS) Surges on Positive Data on Lead Candidate", "Dr. Reddy's (RDY) Relaunches Generic Nexium in the U.S.", "Discovery Laboratories Advances Respiratory Disease Drug", "Zacks.com featured expert Kevin Matras highlights: Silicon Motion Technology, Orbotech, Northern Tier Energy, Horizon Pharma and Air Methods", "XBiotech's (XBIT) Cancer Drug Meets Endpoint, Shares Up", "PEG Ratio vs. the P/E Ratio", "Epizyme Updates Non-Hodgkin Lymphoma Drug Trial Data", "Health Care Sector Update for 12/01/2015: HZNP, XTNT, ORMP", "Horizon's (HZNP) Ravicti Ok'd in EU for Urea Cycle Disorders", "AVEO Licenses Tivozanib European Rights to EUSA Pharma", "Horizon (HZNP) To Acquire Crealta Holdings in a $510M Deal", "Zacks.com featured expert Kevin Matras highlights: Silicon Motion Technology, Orbotech, Northern Tier Energy, Horizon Pharma and Air Methods", "XBiotech's (XBIT) Cancer Drug Meets Endpoint, Shares Up", "PEG Ratio vs. the P/E Ratio", "Pre-Market Most Active for Nov 11, 2015 : SMFG, JCP, HZNP, LYG, M, CAJ, BABA, AAPL, QQQ, XLNX, TVIX, FB", "Why Horizon Pharma Is Crashing Today", "Strength Seen in Horizon Pharma (HZNP): Stock Jumps 6.1%", "Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions?", "U.S. Stock Futures Higher on Healthcare Rebound, Nike Buyback", "Health Care Sector Update for 11/20/2015: HZNP, SIRO, VRX", "Horizon (HZNP) Slips, Comments on Express Scripts Charges", "Pre-Market Earnings Report for November 6, 2015 : CI, BAM, HUM, AEE, TCP, HZNP, TPH, ABY, SATS, SSP, VIV, INSM", "Horizon (HZNP): What's in Store this Earnings Season?", "3 Stocks to Buy Now in Biotech", "Horizon Pharma's Stock Briefly Spikes on Investor Update", "Here's Why Horizon Pharma Plc Is Soaring Today", "Friday's ETF Movers: XPH, XRT", "Interesting HZNP Put And Call Options For December 18th", "Horizon Pharma is Now Oversold (HZNP)", "Tuesday's ETF Movers: GDXJ, XPH", "Tuesday Sector Laggards: Drugs, Biotechnology Stocks", "January 2018 Options Now Available For Horizon Pharma (HZNP)", "Monday's ETF Movers: IHE, GDX", "3 Biotech Stocks That Have Been Unfairly Beaten Down", "Health Care Sector Update for 10/02/2015: HZNP, HLS, CLRB", "Interesting HZNP Put And Call Options For May 2016", "How the bulls are playing Horizon", "Horizon Pharma is Now Oversold (HZNP)", "Horizon Pharma (HZNP) in Focus: Stock Plunges 12%", "Health Care Sector Update for 09/22/2015: STJ, VBLT, HZNP", "4 Biotech Stocks Now at Bargain Prices", "Use Options For a Chance To Buy HZNP at a 52% Discount", "Bulls returning to Horizon Pharma", "Health Care Sector Update for 09/02/2015: MRK, GHDX, HZNP", "First Week of October 16th Options Trading For Horizon Pharma (HZNP)", "Health Care Sector Update for 08/27/2015: TBIO, RDHL, HZNP", "Call buyers come back to Horizon", "Use Options For a Chance To Buy HZNP at a 53% Discount", "Horizon Pharma (HZNP) Shares Cross Below 200 DMA", "Health Care Sector Update for 08/13/2015: HZNP, ACHN", "Company News for August 10, 2015 - Corporate Summary", "Horizon Pharma (HZNP) Q2 Earnings Up Y/Y, Revenues Beat - Tale of the Tape", "What's Behind Depomed's Soaring Share Price in July?", "Horizon Pharma (HZNP): What's in Store in Q2 Earnings? - Analyst Blog", "Horizon Pharma Up on Expected Q2 Sales, 2015 Outlook - Analyst Blog", "Health Care Sector Update for 07/20/2015: HZNP,EXEL,CRMD", "Horizon Pharma gets vote of confidence", "Horizon's Hostile Bid for DepoMed Is Too Low", "Midday Update: S&P 500 Breaches 200-Day Support With Greece Continuing to Pressure Global Markets", "Why Shares in DepoMed Inc. Are Charging 35% Higher", "Pre-Market Most Active for Jul 7, 2015 : OLN, DCM, BHP, HZNP, FIT, SAN, SIRI, XIV, BP, QQQ, AAPL, TVIX", "Close Update: Wall Street Reverses Course As Technical Support Holds, Greek Deal Hopes Kept Alive", "Health Care Sector Update for 07/07/2015: ESPR,DEPO,HZNP,ETRM", "Health Care Sector Update for 07/07/2015: DEPO,HZNP,PBMD,ETRM", "Bulls rolling with Horizon Pharma", "5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary", "Horizon Pharma (HNZP) Starts Phase III Study on Actimmune - Analyst Blog", "Bulls come back to Horizon Pharma", "Use Options For a Chance To Buy HZNP at a 46% Discount", "Actavis Tops 1Q Earnings by Wide Margin, Provides Outlook - Analyst Blog", "Endo (ENDP) Beats on Q1 Earnings, 2015 Guidance Upped - Analyst Blog", "Merrimack Pharmaceuticals' Q1 Loss Wider Than Expected - Analyst Blog", "3 Moneymaking Biotech Stocks to Consider Buying", "Horizon Pharma (HZNP) Misses Earnings, Upped View - Tale of the Tape", "Earnings Reaction History: Horizon Pharma Inc, 30.0% Follow-Through Indicator, 5.4% Sensitive", "Emergent BioSolutions (EBS) Loss Wider than Expectations - Analyst Blog", "Health Care Sector Update for 05/07/2015: AVEO, ACHN, HZNP", "Pre-Market Earnings Report for May 8, 2015 : HCN, NRG, WWAV, BR, NRF, LVNTA, SIRO, VET, HZNP, LMCA, CST, AOL", "What's in Store for Horizon Pharma (HZNP) in Q1 Earnings? - Analyst Blog", "Regeneron Beats on Q1 Earnings, Eylea 2015 View Upped - Analyst Blog", "Pre-Market Most Active for May 8, 2015 : ALU, NOK, SMLP, QQQ, BABA, XIV, ERIC, AAPL, GSK, SYT, NVDA, HZNP", "Genomic Health Q1 Loss Wider than Expected, Revenues Lag - Analyst Blog", "Prothena (PRTA) Posts Narrower-than-Expected Loss in Q1 - Analyst Blog", "TrovaGene (TROV) Q1 Loss Wider than Expected, Shares Plunge - Analyst Blog", "3 Biotech Stocks in the News", "Aegerion's Q1 Loss Narrower than Expected, View Retained - Analyst Blog", "Zoetis Beats on Q1 Earnings, Revenue Guidance Lowered - Analyst Blog", "Keryx Biopharmaceuticals Posts In-line Loss, Revenue Beat - Analyst Blog", "Myriad Genetics Posts In-Line Q3 Earnings, Guides Lower - Analyst Blog", "Genomic Health Q1 Loss Wider than Expected, Revenues Lag - Analyst Blog", "Prothena (PRTA) Posts Narrower-than-Expected Loss in Q1 - Analyst Blog", "Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog", "Momenta's Q1 Loss Narrower than Expected, Revenues Miss - Analyst Blog", "Valeant Pharmaceuticals Reports In-Line Earnings, Ups View - Analyst Blog", "Bristol-Myers' Supplemental BLA for Opdivo Accepted by FDA - Analyst Blog", "AmerisourceBergen Corp Beats on Q2 Earnings, Ups View - Analyst Blog", "Seattle Genetics Posts Narrower-than-Expected Loss in Q1 - Analyst Blog", "Sanofi's (SNY) Basal Insulin Toujeo Gains European Approval - Analyst Blog", "Celladon's Advanced Heart Failure Study Fails, Shares Crash - Analyst Blog", "Will Horizon Pharma (HZNP) Continue to Surge Higher? - Tale of the Tape", "Eli Lilly's Cyramza Gains FDA Approval for Label Expansion - Analyst Blog", "Intercept Pharmaceuticals Releases Data on Lead Drug - Analyst Blog", "Notable option activity in equities", "Alexion Misses Q1 Earnings Estimates, Keeps 2015 Outlook - Analyst Blog", "United Therapeutics Falls on Q1 Loss, Misses on Revenues - Analyst Blog", "Emergent BioSolutions Resumes BioThrax Manufacturing - Analyst Blog", "Actelion (ALIOF) Beats Q1 Earnings & Revenue Expectations - Analyst Blog", "Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog", "The Medicines Co.'s New Minocin Formulation Approved - Analyst Blog", "Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog", "Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog", "Merck's Keytruda Tops Melanoma, Lung Cancer Studies - Analyst Blog", "Acorda Reports Encouraging Data on MS Drug - Analyst Blog", "3 Top Healthcare Stocks Surging Higher This Year", "Use Options For a Chance To Buy HZNP at a 47% Discount", "Pre-Market Most Active for Apr 17, 2015 : NOK, CNHI, AKBA, XIV, GE, ALU, QQQ, SNE, BAC, AAPL, FB, HZNP", "Actelion to Boost Progress of Specialty Immunology Pipeline - Analyst Blog", "Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog", "Health Care Sector Update for 04/16/2015: ACAD, RCPT, HZNP", "Pre-Market Most Active for Apr 16, 2015 : NOK, ALU, CNHI, C, SNDK, BHP, TSM, HZNP, NFLX, XIV, CPLP, QQQ", "OncoMed Down on Phase Ib Lung Cancer Study Data - Analyst Blog", "3 Top Healthcare Stocks Surging Higher This Year", "Horizon Pharma's Actimmune Gets Fast Track Status - Analyst Blog", "Novo Nordisk's Tresiba & Ryzodeg NDAs under FDA Review - Analyst Blog", "Merck's HCV Combo Drug Gets Two Breakthrough Status - Analyst Blog", "The Zacks Analyst Blog Highlights: Caterpillar, Procter & Gamble, Horizon Pharma, RadNet and PRA Health Sciences - Press Releases", "Clovis Oncology's Rucaparib Gets Breakthrough Status - Analyst Blog", "The Medicines Co.'s Kengreal Backed for FDA Approval - Analyst Blog", "Pre-Market Most Active for Apr 15, 2015 : NOK, ALU, BAC, STWD, KEP, INTC, ERIC, BHP, FOMX, QQQ, AAPL, HZNP", "Aeterna Zentaris to Advance Hormone Drug to Phase III Study - Analyst Blog", "Horizon Pharma's Actimmune Gets Fast Track Status - Analyst Blog", "The Zacks Analyst Blog Highlights: Horizon Pharma, Hyperion Therapeutics, Conatus, Amgen and Biogen - Press Releases", "Repros' Secondary Hypogonadism Drug Under FDA Review - Analyst Blog", "Dyax's Hereditary Angioedema Drug Meets Primary Endpoint - Analyst Blog", "Sarepta CEO Exits, Eteplirsen Regulatory Filing on Track - Analyst Blog", "3 Top Small-Cap Growth Stocks Building Momentum Now - Stocks in the News", "Horizon Pharma to Buy Hyperion Therapeutics for $1.1B - Analyst Blog", "Strength Seen in Horizon Pharma (HZNP): Stock Rises 18.2% - Tale of the Tape", "Amgen's Kyprolis Gets FDA Priority Review for Expanded Use - Analyst Blog", "Midday Update: Stocks Rally on M&A Deals, China's New 'Silk Road', Bullish Home Sales", "Notable option activity in equities", "Why Horizon Pharma Plc Is Soaring Today", "DreamWorks scores big with \"Home\"", "Biotech Stock Roundup: Horizon to Buy Hyperion, Conatus Up on Liver Disease Data - Analyst Blog", "U.S. Stock Futures Gain Before Data; Health-Care Deals Dominate", "Calls win big in Horizon Pharma", "The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases", "Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog", "Momentum bulls stick with Horizon", "Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog", "Heat Biologics Posts Wider Loss Y/Y, Focus on Pipeline - Analyst Blog", "Lpath (LPTN) Crumbles on Failure of Kidney Cancer Drug Trial - Analyst Blog", "3 Excellent Biotech Stocks to Buy on the Dip - Stocks in the News", "Isis Pharmaceuticals Reports Phase I Data on Lipid Candidate - Analyst Blog", "Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - Analyst Blog", "Novo Nordisk's Saxenda Gets EU Approval for Obesity - Analyst Blog", "Amicus to Seek for Migalastat's Approval in the U.S., EU - Analyst Blog", "Eli Lilly Collaborates with Korean Hanmi Pharmaceutical - Analyst Blog", "Regeneron's Eylea Gets FDA Approval for Label Expansion - Analyst Blog", "Kite Pharma (KITE) Acquires T-Cell Factory, Focus on Europe - Analyst Blog", "Actelion's Uptravi Shows Long-term Benefit in GRIPHON - Analyst Blog", "Merck's Sugammadex Faces Setback, FDA Delays Meeting - Analyst Blog", "Synta's Q4 Loss Narrows Y/Y, Focus on Lung Cancer Drug - Analyst Blog", "Emergent BioSolutions, MorphoSys Start Cancer Drug Study - Analyst Blog", "Strength Seen in Horizon Pharma (HZNP): Stock Rises 5.1% - Tale of the Tape", "Osiris Therapeutics' Q4 Earnings Down Y/Y, Revenues Soar - Analyst Blog", "Lexicon-Ipsen Agreement Expanded to Include Canada - Analyst Blog", "Health Care Sector Update for 03/06/2015: CALA, ISIS, HZNP", "Bristol-Myers Oncology Drug Opdivo Label Expanded in U.S. - Analyst Blog", "Merck Inks Deal with Eisai for Cancer Combo Therapy - Analyst Blog", "Can the Rally in Horizon Pharma (HZNP) Shares Continue? - Tale of the Tape", "Orexigen Soars as Interim Data on Contrave Comes to Light - Analyst Blog", "Jazz Pharmaceuticals Up on U.S. Approval of Xyrem REMS - Analyst Blog", "Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog", "Emergent BioSolutions Lags Earnings, Cancels 2015 View - Analyst Blog", "Bristol-Myers Files for New Indications for Yervoy, Opdivo - Analyst Blog", "Horizon Pharma Beats on Q4 Earnings, Lifts 2015 Guidance - Analyst Blog", "Health Care Sector Update for 02/27/2015: PCYC, HZNP, BVX", "Pre-Market Most Active for Feb 27, 2015 : ROVI, TOT, JCP, BLMN, BAC, HMC, PBR, FCAU, TVIX, AAPL, CLNE, HZNP", "Pre-Market Earnings Report for February 27, 2015 : IEP, NRG, ISIS, HPT, XLS, NRF, CST, RDC, KBR, PTCT, PNM, HZNP", "Why Horizon Pharma PLC Stock Skyrocketed Today", "Will ARIAD (ARIA) Impress on Iclusig Sales this Earnings? - Analyst Blog", "Amgen-Celimmune Tie Up for Autoimmune Disorder Drug - Analyst Blog", "Health Care Sector Update for 12/26/2014: NVS, HZNP, ACT", "Cheap Stocks for 2015: The Best Buys in Healthcare", "Sector Update: Health Care", "Sector Update: Health Stocks Generally Flat Pre-Bell", "Will Horizon Pharma (HZNP) Earnings Surprise This Season? - Analyst Blog", "Sector Update: Health Stocks Higher Pre-Bell", "Sector Update: Health Care", "Commit To Buy Horizon Pharma At $10, Earn 16% Using Options", "Sector Update: Smaller Rise for Health Care Stocks Today; Horizon Pharma Turns Lower Despite Positive Test for New Actimmune Use", "Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog", "3 Best Performing Stocks in September - Analyst Blog", "NASDAQ Biotechnology Top Performers (As Of Market Open September 11)", "Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog", "Pre-Market Most Active for Jul 28, 2014 : FDO, DLTR, ACRX, HZNP, TRLA, LOCO, SNY, DG, BHP, GSK, FB, AAPL", "Monday Sector Laggards: Metals Fabrication & Products, Drugs", "Sector Update: Health Care", "Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog", "Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog", "Monday's ETF Movers: GDXJ, IBB", "Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape", "Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape", "Sector Update: Healthcare Shares Flat to Higher; Horizon Pharma up 9% on Q1 Results", "Sector Update: Healthcare", "A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week", "Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape", "Commit To Buy Horizon Pharma At $10, Earn 19.1% Annualized Using Options", "Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape", "Roundtable Top Picks for the Week of Mar. 24th - Video Blog", "Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog", "Healthcare Stocks Crawling Higher; Horizon Pharma Shares Jump Over 14% After Deal for Vidara Therapeutics", "Sector Update: Healthcare", "Earnings Reaction History: Horizon Pharma Inc, 14.3% Follow-Through Indicator, 6.7% Sensitive", "US Futures Barely Higher Ahead of Fed Statement", "Pre-Market Most Active for Mar 19, 2014 : VZ, RDS/A, HZNP, ORCL, QQQ, NOK, SNY, FCEL, KNDI, GERN, SIRI, BP", "After Hours Most Active for Mar 19, 2014 : BTU, JPM, QQQ, WFC, BPO, STAG, MET, GILD, HZNP, ADSK, CSCO, MSFT", "Horizon Pharma (HZNP) Jumps: Stock Rises 5.6% - Tale of the Tape", "Horizon Pharma Banks On Two-For-One Arthritis Drugs", "Sector Update: Health Care", "Sector Update: Health-Care Shares Mixed Pre-Market; Progenics Up 3% on Smaller-Than-Expected Q4 Loss", "US Futures Slightly Higher Ahead of Yellen's First FOMC Presser; Oracle Misses Views", "Should You Worry About the Short Interest in Horizon Pharma (HZNP)? - Tale of the Tape", "Horizon Pharma (HZNP) Shares March Higher, Can It Continue? - Tale of the Tape", "Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2% - Tale of the Tape", "Affymetrix's Revenue Guidance Tops Ests - Analyst Blog", "Patients Enrolled in Synageva Study - Analyst Blog", "After Hours Most Active for Dec 19, 2013 : BAC, CSCO, QQQ, PKY, MSFT, MS, HZNP, JPM, GE, HSBC, ATVI, MU", "In Insider Trading, Blackstone Sells Majority of SeaWorld Shares", "Biopharms That Won't Buy The Farm - Investment Ideas", "Horizon Pharma Inc (HZNP) Enters Overbought Territory - Tale of the Tape", "Actavis in Patent Infringement Case - Analyst Blog", "Horizon Pharma Settles with Par Pharma - Analyst Blog", "Sector Update: Healthcare Shares Lower; Progenix Narrows Q2 Net Loss", "Sector Update: Healthcare", "Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO", "Pre-Market Earnings Report for August 10, 2012 : BAM, JCP, HAR, CYD, HSFT, CLDX, HZNP, SCR, XIN, URRE, HSKA, DLGC", "Pre-Market Most Active for Nov 19, 2013 : EXXI, NCT, ALU, AEG, BBVA, BBY, HSBC, HZNP, TSLA, FB, VOD, SLM", "Earnings Preview: Covidien - Analyst Blog", "Covidien Teams Up with Horizon - Analyst Blog", "The New Pfizer: 6 Drug Companies with Bullish Short Trends", "Mixed 3Q for Covidien, Profit Drops - Analyst Blog"], "Elapsed Time": ["3 DAYS AGO", "MAY 6, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 6, 2020", "APR 24, 2020", "APR 15, 2020", "3 DAYS AGO", "MAR 14, 2020", "MAR 12, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "JAN 23, 2020", "APR 3, 2020", "JAN 21, 2020", "JAN 21, 2020", "JAN 2, 2020", "DEC 27, 2019", "DEC 18, 2019", "DEC 12, 2019", "NOV 24, 2019", "JAN 23, 2020", "NOV 6, 2019", "NOV 6, 2019", "OCT 30, 2019", "AUG 7, 2019", "AUG 5, 2019", "AUG 2, 2019", "JUL 19, 2019", "NOV 11, 2019", "APR 17, 2019", "APR 16, 2019", "APR 11, 2019", "MAR 6, 2019", "MAR 4, 2019", "MAR 1, 2019", "MAR 1, 2019", "JUL 15, 2019", "MAR 1, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "MAR 1, 2019", "MAR 1, 2019", "FEB 5, 2019", "FEB 5, 2019", "JAN 15, 2019", "JAN 15, 2019", "JAN 2, 2019", "DEC 29, 2018", "FEB 27, 2019", "FEB 20, 2019", "FEB 5, 2019", "FEB 5, 2019", "JAN 15, 2019", "NOV 7, 2018", "NOV 7, 2018", "DEC 28, 2018", "DEC 20, 2018", "SEP 7, 2018", "SEP 5, 2018", "SEP 4, 2018", "AUG 24, 2018", "AUG 22, 2018", "NOV 5, 2018", "NOV 5, 2018", "OCT 31, 2018", "SEP 7, 2018", "AUG 8, 2018", "AUG 6, 2018", "AUG 6, 2018", "AUG 2, 2018", "AUG 10, 2018", "JUL 27, 2018", "JUL 25, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 3, 2018", "JUN 27, 2018", "JUL 31, 2018", "JUN 1, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 7, 2018", "JUN 8, 2018", "MAY 3, 2018", "MAY 2, 2018", "APR 20, 2018", "APR 18, 2018", "APR 18, 2018", "APR 17, 2018", "APR 6, 2018", "MAY 7, 2018", "MAY 3, 2018", "MAY 2, 2018", "APR 20, 2018", "APR 18, 2018", "APR 18, 2018", "APR 17, 2018", "MAR 26, 2018", "APR 6, 2018", "APR 5, 2018", "APR 4, 2018", "APR 2, 2018", "APR 2, 2018", "MAR 20, 2018", "MAR 19, 2018", "MAR 26, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 12, 2018", "MAR 9, 2018", "MAR 5, 2018", "MAR 2, 2018", "FEB 28, 2018", "MAR 15, 2018", "MAR 14, 2018", "FEB 12, 2018", "JAN 31, 2018", "JAN 10, 2018", "DEC 31, 2017", "DEC 28, 2017", "DEC 27, 2017", "FEB 28, 2018", "DEC 6, 2017", "NOV 7, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 2, 2017", "DEC 15, 2017", "DEC 14, 2017", "DEC 6, 2017", "NOV 7, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 2, 2017", "OCT 30, 2017", "OCT 17, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 18, 2017", "AUG 17, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 4, 2017", "JUL 31, 2017", "JUL 10, 2017", "JUN 27, 2017", "AUG 7, 2017", "JUN 20, 2017", "JUN 12, 2017", "JUN 8, 2017", "MAY 31, 2017", "MAY 30, 2017", "MAY 25, 2017", "MAY 9, 2017", "JUN 26, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 5, 2017", "MAY 4, 2017", "MAY 3, 2017", "MAY 3, 2017", "APR 18, 2017", "APR 7, 2017", "MAR 30, 2017", "MAY 5, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 24, 2017", "FEB 24, 2017", "FEB 23, 2017", "MAR 17, 2017", "FEB 6, 2017", "JAN 30, 2017", "JAN 27, 2017", "JAN 24, 2017", "DEC 29, 2016", "DEC 27, 2016", "DEC 16, 2016", "FEB 19, 2017", "DEC 9, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 16, 2016", "DEC 9, 2016", "DEC 8, 2016", "DEC 8, 2016", "NOV 8, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 29, 2016", "NOV 7, 2016", "NOV 4, 2016", "NOV 1, 2016", "OCT 21, 2016", "OCT 12, 2016", "OCT 11, 2016", "OCT 3, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 4, 2016", "NOV 1, 2016", "OCT 21, 2016", "SEP 14, 2016", "SEP 13, 2016", "SEP 30, 2016", "SEP 30, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 13, 2016", "SEP 5, 2016", "SEP 2, 2016", "AUG 19, 2016", "AUG 18, 2016", "AUG 16, 2016", "AUG 10, 2016", "AUG 9, 2016", "SEP 12, 2016", "SEP 5, 2016", "SEP 2, 2016", "AUG 19, 2016", "AUG 18, 2016", "AUG 16, 2016", "AUG 10, 2016", "AUG 4, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 8, 2016", "JUL 11, 2016", "JUL 7, 2016", "JUN 30, 2016", "JUN 30, 2016", "JUN 29, 2016", "AUG 2, 2016", "JUN 1, 2016", "MAY 25, 2016", "MAY 20, 2016", "MAY 10, 2016", "MAY 9, 2016", "MAY 9, 2016", "MAY 9, 2016", "JUN 10, 2016", "MAY 9, 2016", "MAY 5, 2016", "MAY 5, 2016", "MAY 4, 2016", "MAY 4, 2016", "APR 19, 2016", "APR 15, 2016", "MAY 9, 2016", "MAY 9, 2016", "MAY 5, 2016", "APR 13, 2016", "APR 12, 2016", "APR 12, 2016", "APR 12, 2016", "APR 12, 2016", "APR 14, 2016", "APR 13, 2016", "APR 13, 2016", "APR 8, 2016", "APR 8, 2016", "APR 7, 2016", "APR 7, 2016", "APR 6, 2016", "APR 12, 2016", "MAR 30, 2016", "MAR 24, 2016", "MAR 23, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 21, 2016", "MAR 21, 2016", "APR 5, 2016", "MAR 30, 2016", "MAR 24, 2016", "MAR 23, 2016", "MAR 10, 2016", "MAR 10, 2016", "MAR 10, 2016", "MAR 9, 2016", "MAR 17, 2016", "MAR 9, 2016", "MAR 4, 2016", "MAR 3, 2016", "MAR 2, 2016", "MAR 1, 2016", "MAR 1, 2016", "MAR 1, 2016", "MAR 9, 2016", "MAR 1, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "MAR 1, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 24, 2016", "FEB 15, 2016", "FEB 23, 2016", "FEB 9, 2016", "FEB 5, 2016", "FEB 5, 2016", "FEB 4, 2016", "FEB 3, 2016", "JAN 29, 2016", "JAN 27, 2016", "FEB 9, 2016", "JAN 26, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 22, 2016", "JAN 22, 2016", "JAN 21, 2016", "JAN 26, 2016", "JAN 26, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 14, 2016", "JAN 14, 2016", "JAN 14, 2016", "JAN 20, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 12, 2016", "JAN 11, 2016", "JAN 8, 2016", "JAN 7, 2016", "JAN 7, 2016", "JAN 7, 2016", "JAN 12, 2016", "JAN 6, 2016", "JAN 5, 2016", "JAN 5, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 4, 2016", "DEC 31, 2015", "JAN 6, 2016", "DEC 30, 2015", "DEC 30, 2015", "DEC 29, 2015", "DEC 29, 2015", "DEC 29, 2015", "DEC 28, 2015", "DEC 24, 2015", "DEC 31, 2015", "DEC 30, 2015", "DEC 9, 2015", "DEC 8, 2015", "DEC 8, 2015", "DEC 8, 2015", "DEC 1, 2015", "DEC 1, 2015", "DEC 22, 2015", "DEC 14, 2015", "DEC 9, 2015", "DEC 8, 2015", "NOV 11, 2015", "NOV 11, 2015", "NOV 11, 2015", "NOV 10, 2015", "NOV 30, 2015", "NOV 20, 2015", "NOV 20, 2015", "NOV 12, 2015", "NOV 5, 2015", "NOV 4, 2015", "NOV 2, 2015", "NOV 9, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 21, 2015", "OCT 20, 2015", "OCT 20, 2015", "OCT 20, 2015", "OCT 12, 2015", "OCT 26, 2015", "OCT 6, 2015", "OCT 2, 2015", "SEP 28, 2015", "SEP 24, 2015", "SEP 24, 2015", "SEP 23, 2015", "SEP 22, 2015", "OCT 9, 2015", "SEP 18, 2015", "SEP 18, 2015", "SEP 2, 2015", "AUG 28, 2015", "AUG 27, 2015", "AUG 26, 2015", "AUG 18, 2015", "SEP 22, 2015", "AUG 13, 2015", "AUG 10, 2015", "AUG 7, 2015", "AUG 6, 2015", "AUG 5, 2015", "JUL 21, 2015", "JUL 20, 2015", "AUG 18, 2015", "JUL 9, 2015", "JUL 7, 2015", "JUL 7, 2015", "JUL 7, 2015", "JUL 7, 2015", "JUL 7, 2015", "JUL 7, 2015", "JUL 17, 2015", "JUN 17, 2015", "JUN 8, 2015", "JUN 2, 2015", "MAY 21, 2015", "MAY 11, 2015", "MAY 11, 2015", "MAY 8, 2015", "JUL 5, 2015", "MAY 8, 2015", "MAY 8, 2015", "MAY 8, 2015", "MAY 7, 2015", "MAY 7, 2015", "MAY 7, 2015", "MAY 7, 2015", "MAY 8, 2015", "MAY 6, 2015", "MAY 6, 2015", "MAY 6, 2015", "MAY 5, 2015", "MAY 5, 2015", "MAY 5, 2015", "MAY 5, 2015", "MAY 6, 2015", "MAY 6, 2015", "MAY 6, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 1, 2015", "MAY 1, 2015", "APR 30, 2015", "MAY 4, 2015", "APR 29, 2015", "APR 28, 2015", "APR 27, 2015", "APR 27, 2015", "APR 24, 2015", "APR 23, 2015", "APR 23, 2015", "APR 29, 2015", "APR 23, 2015", "APR 22, 2015", "APR 22, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 20, 2015", "APR 23, 2015", "APR 18, 2015", "APR 17, 2015", "APR 17, 2015", "APR 16, 2015", "APR 16, 2015", "APR 16, 2015", "APR 16, 2015", "APR 20, 2015", "APR 18, 2015", "APR 13, 2015", "APR 9, 2015", "APR 9, 2015", "APR 7, 2015", "APR 7, 2015", "APR 16, 2015", "APR 15, 2015", "APR 14, 2015", "APR 13, 2015", "APR 2, 2015", "APR 2, 2015", "APR 1, 2015", "APR 1, 2015", "APR 7, 2015", "MAR 31, 2015", "MAR 31, 2015", "MAR 31, 2015", "MAR 30, 2015", "MAR 30, 2015", "MAR 30, 2015", "MAR 30, 2015", "APR 1, 2015", "MAR 30, 2015", "MAR 30, 2015", "MAR 27, 2015", "MAR 27, 2015", "MAR 26, 2015", "MAR 26, 2015", "MAR 30, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 24, 2015", "MAR 24, 2015", "MAR 24, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 26, 2015", "MAR 18, 2015", "MAR 16, 2015", "MAR 16, 2015", "MAR 13, 2015", "MAR 10, 2015", "MAR 9, 2015", "MAR 6, 2015", "MAR 19, 2015", "MAR 6, 2015", "MAR 6, 2015", "MAR 6, 2015", "MAR 4, 2015", "MAR 4, 2015", "MAR 4, 2015", "MAR 3, 2015", "MAR 6, 2015", "MAR 3, 2015", "MAR 2, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 26, 2015", "FEB 20, 2015", "FEB 18, 2015", "MAR 3, 2015", "DEC 26, 2014", "DEC 10, 2014", "NOV 6, 2014", "NOV 6, 2014", "NOV 5, 2014", "OCT 17, 2014", "OCT 17, 2014", "JAN 29, 2015", "OCT 14, 2014", "OCT 7, 2014", "OCT 1, 2014", "SEP 11, 2014", "AUG 6, 2014", "JUL 28, 2014", "JUL 28, 2014", "OCT 14, 2014", "JUL 2, 2014", "JUL 2, 2014", "JUN 23, 2014", "JUN 2, 2014", "MAY 29, 2014", "MAY 9, 2014", "MAY 9, 2014", "JUL 8, 2014", "MAY 1, 2014", "APR 7, 2014", "MAR 25, 2014", "MAR 24, 2014", "MAR 20, 2014", "MAR 19, 2014", "MAR 19, 2014", "MAY 9, 2014", "MAR 19, 2014", "MAR 19, 2014", "MAR 19, 2014", "MAR 18, 2014", "MAR 14, 2014", "MAR 13, 2014", "MAR 13, 2014", "MAR 19, 2014", "FEB 24, 2014", "FEB 21, 2014", "JAN 30, 2014", "JAN 8, 2014", "JAN 7, 2014", "DEC 19, 2013", "DEC 18, 2013", "FEB 27, 2014", "SEP 18, 2013", "AUG 28, 2013", "AUG 26, 2013", "AUG 9, 2013", "AUG 9, 2013", "MAR 15, 2013", "AUG 9, 2012", "NOV 19, 2013", "JUL 23, 2012", "JUN 19, 2012", "DEC 15, 2011", "JUL 26, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/hznp-crosses-above-average-analyst-target-2020-06-25", "https://www.nasdaq.com/articles/horizon-therapeutics-plc-hznp-q1-2020-earnings-call-transcript-2020-05-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-06-2020%3A-sdcaetunhhznptgtxsilk-2020-05-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-06-2020%3A-hznptgtxsilk-2020-05-06", "https://www.nasdaq.com/articles/why-horizon-therapeutics-is-soaring-today-2020-05-06", "https://www.nasdaq.com/articles/stock-alert%3A-horizon-therapeutics-up-9-2020-05-06", "https://www.nasdaq.com/articles/first-week-of-june-19th-options-trading-for-horizon-therapeutics-hznp-2020-04-24", "https://www.nasdaq.com/articles/should-you-buy-these-4-biotech-stocks-with-recent-drug-approvals-2020-04-15", "https://www.nasdaq.com/articles/hznp-crosses-above-average-analyst-target-2020-06-25", "https://www.nasdaq.com/articles/buy-this-1-pharma-stock-to-outperform-the-bear-market-2020-03-14", "https://www.nasdaq.com/articles/hznp-makes-notable-cross-below-critical-moving-average-2020-03-12", "https://www.nasdaq.com/articles/horizon-therapeutics-plc-hznp-q4-2019-earnings-call-transcript-2020-02-26", "https://www.nasdaq.com/articles/horizon-therapeutics-plc-hznp-q4-2019-earnings-call-transcript-2020-02-26-0", "https://www.nasdaq.com/articles/horizon-therapeutics-reports-q4-results-beats-revenue-target-2020-02-26", "https://www.nasdaq.com/articles/stock-alert%3A-horizon-therapeutics-hznp-2020-02-26", "https://www.nasdaq.com/articles/horizon-therapeutics-gets-fda-approval-for-eye-drug-2020-01-23", "https://www.nasdaq.com/articles/should-you-buy-these-3-biotechs-now-2020-04-03", "https://www.nasdaq.com/articles/first-drug-for-ted-secures-approval-trov-on-watch-evok-faces-fda-in-june-2020-01-21", "https://www.nasdaq.com/articles/fda-approves-first-ever-treatment-for-thyroid-eye-disease-2020-01-21", "https://www.nasdaq.com/articles/3-healthcare-stocks-primed-for-2020-gains-2020-01-02", "https://www.nasdaq.com/articles/first-week-of-august-2020-options-trading-for-horizon-therapeutics-hznp-2019-12-27", "https://www.nasdaq.com/articles/horizon-therapeutics-rally-may-be-short-lived-as-investors-wait-for-key-date-in-march-2019", "https://www.nasdaq.com/articles/4-healthcare-stocks-with-fda-approvals-on-the-horizon-2019-12-12", "https://www.nasdaq.com/articles/sp-500%3A-winning-streak-ends-2019-11-24", "https://www.nasdaq.com/articles/first-week-of-hznp-march-20th-options-trading-2020-01-23", "https://www.nasdaq.com/articles/horizon-pharma-plc-hznp-q3-2019-earnings-call-transcript-2019-11-06", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-reta-flgt-hznp...-2019-11-06", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-gsk-nvo-nvst...-2019-10-30", "https://www.nasdaq.com/articles/horizon-pharma-plc-hznp-q2-2019-earnings-call-transcript-2019-08-07", "https://www.nasdaq.com/articles/hznp-crosses-below-key-moving-average-level-2019-08-05", "https://www.nasdaq.com/articles/first-week-of-hznp-september-20th-options-trading-2019-08-02", "https://www.nasdaq.com/articles/bmy-to-explore-stivarga-opdivo-combo-myok-ahead-of-timeline-unh-on-watch-2019-07-19", "https://www.nasdaq.com/articles/3-market-beating-stocks-for-your-2020-radar-2019-11-11", "https://www.nasdaq.com/articles/relative-strength-alert-horizon-pharma-2019-04-17", "https://www.nasdaq.com/articles/recordati-seek-canadian-approval-kidney-disease-drug-2019-04-16", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-guru-2019-04-11", "https://www.nasdaq.com/articles/health-care-sector-update-03062019-hznpinfihcrvstmsrptlgndnvs-2019-03-06", "https://www.nasdaq.com/articles/3-high-growth-stocks-are-just-getting-started-2019-03-04", "https://www.nasdaq.com/articles/company-news-for-mar-1-2019-2019-03-01", "https://www.nasdaq.com/articles/why-these-pharma-etfs-rallied-thursday-2019-03-01", "https://www.nasdaq.com/articles/commit-to-buy-horizon-therapeutics-at-%2415-earn-9-using-options-2019-07-15", "https://www.nasdaq.com/articles/3-big-stock-charts-for-friday%3A-eli-lilly-centene-and-lkq-corporation-2019-03-01", "https://www.nasdaq.com/articles/mid-day-market-update-veritiv-falls-after-q4-results-horizon-pharma-shares-surge-2019-02", "https://www.nasdaq.com/articles/why-horizon-pharma-surging-today-2019-02-28", "https://www.nasdaq.com/articles/horizon-pharmas-hznp-stock-up-on-q4-earnings-sales-beat-2019-02-28", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-j-c-penney-profit-beats-expectations-2019-02", "https://www.nasdaq.com/articles/why-monster-beverage-horizon-pharma-and-guardant-health-jumped-today-2019-02-28", "https://www.nasdaq.com/articles/mid-afternoon-market-update-box-drops-weak-forecast-arcadia-biosciences-shares-gain-2019", "https://www.nasdaq.com/articles/horizon-pharma-reaches-analyst-target-price-2019-03-01", "https://www.nasdaq.com/articles/3-big-stock-charts-for-friday%3A-eli-lilly-centene-and-lkq-corporation-2019-03-01", "https://www.nasdaq.com/articles/health-care-sector-update-02052019-mrnaarryhznphae-2019-02-05", "https://www.nasdaq.com/articles/health-care-sector-update-02052019-arryhznphae-2019-02-05", "https://www.nasdaq.com/articles/hznp-april-18th-options-begin-trading-2019-01-15", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-horizon-pharma-hznp-stock-we-dont-2019-01-15", "https://www.nasdaq.com/articles/horizon-pharma-hznp-up-28-on-business-expansion-strategy-2019-01-02", "https://www.nasdaq.com/articles/3-top-mid-cap-stocks-buy-right-now-2018-12-29", "https://www.nasdaq.com/articles/horizon-pharma-plc-hznp-q4-2018-earnings-conference-call-transcript-2019-02-27", "https://www.nasdaq.com/articles/horizon-pharma-hznp-earnings-expected-to-grow%3A-what-to-know-ahead-of-next-weeks-release", "https://www.nasdaq.com/articles/health-care-sector-update-02052019-mrnaarryhznphae-2019-02-05", "https://www.nasdaq.com/articles/health-care-sector-update-02052019-arryhznphae-2019-02-05", "https://www.nasdaq.com/articles/hznp-april-18th-options-begin-trading-2019-01-15", "https://www.nasdaq.com/articles/horizon-pharma-hznp-tops-q3-earnings-and-revenue-estimates-2018-11-07", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-636-follow-through-indicator-91-sensitive", "https://www.nasdaq.com/articles/horizon-pharmas-ravicti-gets-fda-nod-for-expanded-age-group-2018-12-28", "https://www.nasdaq.com/articles/hznp-december-2020-options-begin-trading-2018-12-20", "https://www.nasdaq.com/articles/horizon-pharma-hznp-down-1.9-since-last-earnings-report%3A-can-it-rebound-2018-09-07", "https://www.nasdaq.com/articles/horizon-pharma-completes-enrollment-in-eye-disease-study-2018-09-05", "https://www.nasdaq.com/articles/first-week-october-19th-options-trading-horizon-pharma-hznp-2018-09-04", "https://www.nasdaq.com/articles/these-3-value-stocks-are-absurdly-cheap-right-now-2018-08-24", "https://www.nasdaq.com/articles/horizon-pharma-hznp-boasts-robust-pipeline-amid-competition-2018-08-22", "https://www.nasdaq.com/articles/is-a-disappointment-in-store-for-tilray-tlry-q3-earnings-2018-11-05", "https://www.nasdaq.com/articles/endo-endp-to-report-q3-earnings%3A-whats-in-the-cards-2018-11-05", "https://www.nasdaq.com/articles/horizon-pharma-hznp-earnings-expected-to-grow%3A-what-to-know-ahead-of-next-weeks-release-0", "https://www.nasdaq.com/articles/horizon-pharma-hznp-down-1.9-since-last-earnings-report%3A-can-it-rebound-2018-09-07", "https://www.nasdaq.com/articles/heres-why-horizon-pharma-plc-rose-double-digits-today-2018-08-08", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-horizon-pharma-hznp-in-q2-earnings-2018-08-06", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-biodelivery-bdsi-in-q2-earnings-2018-08-06", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-nektar-nktr-in-q2-earnings-2018-08-02", "https://www.nasdaq.com/articles/hznp-crosses-above-average-analyst-target-2018-08-10", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2018-07-27", "https://www.nasdaq.com/articles/whats-in-store-for-immunogen-imgn-this-earnings-season-2018-07-25", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-07-23", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-bristol-myers-bmy-in-q2-earnings-2018-07-23", "https://www.nasdaq.com/articles/7-healthcare-stocks-that-are-coming-to-life-2018-07-23", "https://www.nasdaq.com/articles/10-underappreciated-biotech-stocks-buy-2018-07-03", "https://www.nasdaq.com/articles/implied-iyh-analyst-target-price-205-2018-06-27", "https://www.nasdaq.com/articles/what-lies-in-store-for-ligand-lgnd-this-earnings-season-2018-07-31", "https://www.nasdaq.com/articles/kitov-ktov-gets-approval-from-fda-for-consensi-shares-up-2018-06-01", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q1-earnings-sales-miss-shares-fall-2018-05-10", "https://www.nasdaq.com/articles/hznp-makes-notable-cross-below-critical-moving-average-2018-05-09", "https://www.nasdaq.com/articles/health-care-sector-update-05092018-hznp-myl-lpcn-argx-2018-05-09", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q1-loss-wider-revenues-miss-2018-05-09", "https://www.nasdaq.com/articles/health-care-sector-update-05092018-hznpmyllpcn-2018-05-09", "https://www.nasdaq.com/articles/interesting-hznp-put-and-call-options-november-16th-2018-05-07", "https://www.nasdaq.com/articles/why-is-horizon-pharma-hznp-up-18.3-since-its-last-earnings-report-2018-06-08", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-western-digital-daqo-new-energy-horizon-pharma-public-and-american", "https://www.nasdaq.com/articles/4-low-p-cf-stocks-ready-to-add-value-to-your-investment-2018-05-02", "https://www.nasdaq.com/articles/eleven-biotherapeutics-ebio-in-focus%3A-stock-moves-8.7-higher-2018-04-20", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-western-digital-arcelormittal-arrow-electronics-and-horizon-pharma", "https://www.nasdaq.com/articles/enhance-your-portfolio-with-these-5-low-price-to-book-stocks-2018-04-18", "https://www.nasdaq.com/articles/pick-these-4-low-p-cf-stocks-sail-through-a-volatile-market-2018-04-17", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-11-using-options-2018-04-06", "https://www.nasdaq.com/articles/whats-in-store-for-horizon-pharma-hznp-in-q1-earnings-2018-05-07", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-western-digital-daqo-new-energy-horizon-pharma-public-and-american", "https://www.nasdaq.com/articles/4-low-p-cf-stocks-ready-to-add-value-to-your-investment-2018-05-02", "https://www.nasdaq.com/articles/eleven-biotherapeutics-ebio-in-focus%3A-stock-moves-8.7-higher-2018-04-20", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-western-digital-arcelormittal-arrow-electronics-and-horizon-pharma", "https://www.nasdaq.com/articles/enhance-your-portfolio-with-these-5-low-price-to-book-stocks-2018-04-18", "https://www.nasdaq.com/articles/recession-cards-4-safe-bets-your-portfolio-2018-03-29", "https://www.nasdaq.com/articles/pfizers-chantix-fails-in-phase-iv-study-in-young-smokers-2018-03-26", "https://www.nasdaq.com/articles/4-drugbiotech-stocks-buy-ahead-world-health-day-2018-04-06", "https://www.nasdaq.com/articles/conatus-emricasan-fails-in-phase-ii-study-shares-sink-2018-04-05", "https://www.nasdaq.com/articles/pick-these-5-winning-stocks-based-on-a-favorable-p-b-ratio-2018-04-04", "https://www.nasdaq.com/articles/amgens-blincyto-gets-fda-nod-for-minimum-residual-disease-2018-04-02", "https://www.nasdaq.com/articles/horizon-pharma-hznp-down-3.9-since-earnings-report%3A-can-it-rebound-2018-04-02", "https://www.nasdaq.com/articles/5-valuable-price-to-book-stocks-to-boost-your-portfolio-2018-03-20", "https://www.nasdaq.com/articles/geron-gern-q4-loss-flat-y-y-revenues-surge-shares-up-2018-03-19", "https://www.nasdaq.com/articles/clovis-gets-positive-chmp-opinion-for-ovarian-cancer-drug-2018-03-26", "https://www.nasdaq.com/articles/5-discounted-peg-stocks-for-value-investors-2018-03-14", "https://www.nasdaq.com/articles/sarepta-to-seek-rapid-approval-for-second-dmd-drug-stock-up-2018-03-13", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-thestreet-barclays-horizon-pharma-regions-financial-and-techtarget", "https://www.nasdaq.com/articles/5-cheap-breakout-stocks-explosive-returns-2018-03-09", "https://www.nasdaq.com/articles/5-low-price-to-book-stocks-with-great-growth-prospects-2018-03-05", "https://www.nasdaq.com/articles/horizon-pharma-hznp-tops-q4-earnings-provides-2018-view-2018-03-02", "https://www.nasdaq.com/articles/horizon-pharma-hznp-tops-q4-earnings-revenues-beat-2018-02-28", "https://www.nasdaq.com/articles/is-horizon-pharma-public-hznp-a-great-stock-for-value-investors-right-now-2018-03-15", "https://www.nasdaq.com/articles/5-discounted-peg-stocks-for-value-investors-2018-03-14", "https://www.nasdaq.com/articles/interesting-hznp-put-and-call-options-march-16th-2018-02-12", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-115-using-options-2018-01-31", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-wdfc-ksu-hznp-2018-01-10", "https://www.nasdaq.com/articles/3-top-value-stocks-buy-2018-2017-12-31", "https://www.nasdaq.com/articles/horizon-pharma-gets-fda-nod-for-procysbi-label-expansion-2017-12-28", "https://www.nasdaq.com/articles/horizon-pharma-shows-improved-relative-price-performance-still-shy-benchmark-2017-12-27", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-636-follow-through-indicator-108-sensitive", "https://www.nasdaq.com/articles/depomed-executes-exit-strategy-its-opioid-drug-2017-12-06", "https://www.nasdaq.com/articles/horizon-pharma-hznp-tops-q3-earnings-sales-ups-view-2017-11-07", "https://www.nasdaq.com/articles/horizon-hznp-tops-q3-earnings-shares-2017-11-06", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-727-follow-through-indicator-115-sensitive", "https://www.nasdaq.com/articles/key-predictions-for-q3-earnings-reports-of-myl-hznp-kerx-2017-11-03", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q3-earnings%3A-a-disappointment-in-store-revised-2017-11-02", "https://www.nasdaq.com/articles/stocks-rising-relative-price-strength-horizon-pharma-2017-12-15", "https://www.nasdaq.com/articles/horizon-pharma-earns-rs-rating-upgrade-2017-12-14", "https://www.nasdaq.com/articles/depomed-executes-exit-strategy-its-opioid-drug-2017-12-06", "https://www.nasdaq.com/articles/horizon-pharma-hznp-tops-q3-earnings-sales-ups-view-2017-11-07", "https://www.nasdaq.com/articles/horizon-hznp-tops-q3-earnings-shares-2017-11-06", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-727-follow-through-indicator-115-sensitive", "https://www.nasdaq.com/articles/key-predictions-for-q3-earnings-reports-of-myl-hznp-kerx-2017-11-03", "https://www.nasdaq.com/articles/gurus-holdings-imply-10-gain-potential-2017-11-02", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q3-earnings%3A-a-disappointment-in-store-2017-11-02", "https://www.nasdaq.com/articles/10-zombie-stocks-to-buy-before-they-return-from-the-grave-2017-10-30", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-12-using-options-2017-10-17", "https://www.nasdaq.com/articles/horizon-pharma-plc-hznp-q2-report-sends-shares-surging-2017-08-07", "https://www.nasdaq.com/articles/dow-to-continue-rally-2017-08-07", "https://www.nasdaq.com/articles/can-dow-go-10-straight-2017-08-07", "https://www.nasdaq.com/articles/horizon-pharma-hznp-soars%3A-stock-adds-10.5-in-session-2017-08-18", "https://www.nasdaq.com/articles/iyhs-underlying-holdings-imply-10-gain-potential-2017-08-17", "https://www.nasdaq.com/articles/horizon-pharma-hznp-tops-earnings-q2-shares-2017-08-07", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-818-follow-through-indicator-112-sensitive", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-7-2017-tsn-fdc-bah-dcp-geo-kos-iivi-hae-fold-hznp-fi", "https://www.nasdaq.com/articles/can-horizon-pharma-hznp-spring-a-surprise-in-q2-earnings-2017-07-31", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-8-earn-112-using-options-2017-07-10", "https://www.nasdaq.com/articles/health-care-sector-update-06272017-jnj-pfe-abt-mrk-amgn-arlz-espr-sny-2017-06-27", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-stock-rising-today-2017-08-07", "https://www.nasdaq.com/articles/horizon-pharma-gets-health-canada-approval-for-procysbi-2017-06-20", "https://www.nasdaq.com/articles/horizon-pharma-hznp-up-11.3-since-earnings-report%3A-can-it-continue-2017-06-12", "https://www.nasdaq.com/articles/3-value-stocks-you-probably-havent-considered-2017-06-08", "https://www.nasdaq.com/articles/falling-earnings-estimates-signal-weakness-ahead-for-horizon-pharma-hznp-2017-05-31", "https://www.nasdaq.com/articles/horizon-pharma-enters-oversold-territory-hznp-2017-05-30", "https://www.nasdaq.com/articles/horizon-hznp-sells-european-rights-for-procysbi-quinsair-2017-05-25", "https://www.nasdaq.com/articles/horizon-hznp-falls-on-q1-earnings-miss-guidance-trimmed-2017-05-09", "https://www.nasdaq.com/articles/3-cheap-healthcare-stocks-you-can-buy-right-now-2017-06-26", "https://www.nasdaq.com/articles/pre-market-most-active-may-8-2017-kate-hznp-jd-lyg-ibn-pso-bcs-db-mu-aapl-ctsh-tvix-2017", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-800-follow-through-indicator-75-sensitive", "https://www.nasdaq.com/articles/why-liberty-global-horizon-pharma-and-synchronoss-technologies-slumped-today-2017-05-08", "https://www.nasdaq.com/articles/health-care-sector-update-05082017-kitehznpnvshznp-2017-05-08", "https://www.nasdaq.com/articles/heres-why-shares-horizon-pharma-hznp-are-cratering-today-2017-05-08", "https://www.nasdaq.com/articles/notable-monday-option-activity-opk-htz-hznp-2017-05-08", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-stock-crashing-today-2017-05-08", "https://www.nasdaq.com/articles/horizon-pharma-hznp-misses-q1-earnings-shares-crash-2017-05-08", "https://www.nasdaq.com/articles/mylan-myl-q1-earnings%3A-will-the-stock-pull-a-surprise-2017-05-05", "https://www.nasdaq.com/articles/is-horizon-pharma-hznp-poised-for-a-beat-in-q1-earnings-2017-05-04", "https://www.nasdaq.com/articles/implied-ftxh-analyst-target-price-24-2017-05-03", "https://www.nasdaq.com/articles/whats-in-store-for-mallinckrodt-mnk-this-earnings-season-2017-05-03", "https://www.nasdaq.com/articles/7-most-expensive-prescription-drugs-world-2017-04-18", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-76-annualized-using-options-2017-04-07", "https://www.nasdaq.com/articles/horizon-hznp-down-10.2-since-earnings-report%3A-can-it-rebound-2017-03-30", "https://www.nasdaq.com/articles/should-you-buy-horizon-pharma-plc-hznp-ahead-of-earnings-2017-05-05", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-636-follow-through-indicator-74-sensitive", "https://www.nasdaq.com/articles/why-tesla-amtrust-financial-services-and-horizon-pharma-slumped-today-2017-02-27", "https://www.nasdaq.com/articles/horizon-pharma-hznp-misses-q4-earnings-revenues-2017-02-27", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-axdx-aaoi-hznp-2017-02-24", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-27-2017-amt-fmx-aes-tgna-snh-afsi-tcp-hznp-nghc-kos", "https://www.nasdaq.com/articles/horizon-hznp-q4-earnings%3A-stock-likely-to-disappoint-2017-02-23", "https://www.nasdaq.com/articles/can-horizon-pharma-hznp-be-a-great-stock-for-value-investors-2017-03-17", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-that-are-set-to-rebound-2017-02-06", "https://www.nasdaq.com/articles/xph-jazz-lly-hznp-large-outflows-detected-etf-2017-01-30", "https://www.nasdaq.com/articles/notable-friday-option-activity-mic-msft-hznp-2017-01-27", "https://www.nasdaq.com/articles/sum-parts-guru-could-be-worth-27-2017-01-24", "https://www.nasdaq.com/articles/commit-purchase-horizon-pharma-13-earn-159-annualized-using-options-2016-12-29", "https://www.nasdaq.com/articles/horizons-rare-disease-drug-quinsair-launched-in-canada-2016-12-27", "https://www.nasdaq.com/articles/heres-why-horizon-pharma-stock-jumped-much-168-today-2016-12-16", "https://www.nasdaq.com/articles/3-companies-need-kick-their-ceo-curb-2017-02-19", "https://www.nasdaq.com/articles/horizon-hznp-stock-sinks-friedreichs-ataxia-study-fails-2016-12-09", "https://www.nasdaq.com/articles/hznp-crosses-below-key-moving-average-level-2016-12-08", "https://www.nasdaq.com/articles/horizon-pharma-plc-hznp-stock-plunges-drug-trial-failure-2016-12-08", "https://www.nasdaq.com/articles/wall-street-sees-steady-open-ecb-leaves-rates-unchanged-us-jobless-claims-decline-2016-12", "https://www.nasdaq.com/articles/pre-market-most-active-dec-8-2016-hznp-bac-db-azn-gfi-cs-bcs-tlt-xiv-lulu-qqq-tvix-2016-12", "https://www.nasdaq.com/articles/us-futures-tread-water-european-central-bank-keeps-rates-unchanged-2016-12-08", "https://www.nasdaq.com/articles/why-las-vegas-sands-horizon-pharma-and-idt-slumped-today-2016-12-08", "https://www.nasdaq.com/articles/pre-market-most-active-dec-16-2016-san-gpor-bac-azn-hznp-dcix-tlt-chk-tig-syt-sdrl-qqq", "https://www.nasdaq.com/articles/horizon-hznp-stock-sinks-friedreichs-ataxia-study-fails-2016-12-09", "https://www.nasdaq.com/articles/hznp-crosses-below-key-moving-average-level-2016-12-08", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-stock-slumped-october-2016-11-09", "https://www.nasdaq.com/articles/horizon-hznp-stock-up-despite-q3-earnings-revenue-miss-2016-11-08", "https://www.nasdaq.com/articles/if-hillary-clinton-wins-these-2-beaten-down-stocks-are-buys-2016-11-07", "https://www.nasdaq.com/articles/horizon-hznp-misses-q3-earnings-revenue-estimates-2016-11-07", "https://www.nasdaq.com/articles/health-care-sector-update-11072016-hznp-vrtx-2016-11-07", "https://www.nasdaq.com/articles/top-research-reports-29th-november-2016-2016-11-29", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-jumped-higher-today-2016-11-07", "https://www.nasdaq.com/articles/drug-stocks-earnings-roster-for-nov-7%3A-hznp-acad-more-2016-11-04", "https://www.nasdaq.com/articles/horizon-hznp-q3-earnings-preview%3A-stock-to-disappoint-2016-11-01", "https://www.nasdaq.com/articles/analysts-forecast-10-upside-fnx-2016-10-21", "https://www.nasdaq.com/articles/horizon-hznp-stock-down-on-dull-q3-view-cuts-16-outlook-2016-10-12", "https://www.nasdaq.com/articles/alcoa-inc-aa-stock-punished-after-third-quarter-earnings-miss-2016-10-11", "https://www.nasdaq.com/articles/horizon-pharma-express-scripts-to-settle-rebate-litigation-2016-10-03", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-600-follow-through-indicator-88-sensitive", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-jumped-higher-today-2016-11-07", "https://www.nasdaq.com/articles/drug-stocks-earnings-roster-for-nov-7%3A-hznp-acad-more-2016-11-04", "https://www.nasdaq.com/articles/horizon-hznp-q3-earnings-preview%3A-stock-to-disappoint-2016-11-01", "https://www.nasdaq.com/articles/analysts-forecast-10-upside-fnx-2016-10-21", "https://www.nasdaq.com/articles/inside-recent-surge-biotech-etfs-2016-09-14", "https://www.nasdaq.com/articles/company-news-for-september-13-2016-2016-09-13", "https://www.nasdaq.com/articles/kite-anavex-gw-pharma-help-revive-biotech-sector-chemistry-2016-09-30", "https://www.nasdaq.com/articles/midday-update-stocks-rebound-wall-street-waits-more-rate-clues-2016-09-12", "https://www.nasdaq.com/articles/hznp-rptp-horizon-pharma-plc-stock-jumps-800-million-raptor-pharmaceutical-corp-buy-2016", "https://www.nasdaq.com/articles/horizon-pharmas-pivot-continues-800-million-buyout-raptor-pharmaceuticals-2016-09-12", "https://www.nasdaq.com/articles/forget-sp-500-buy-these-3-high-growth-healthcare-stocks-instead-2016-09-12", "https://www.nasdaq.com/articles/why-raptor-pharmaceuticals-opentext-and-freeport-mcmoran-jumped-today-2016-09-12", "https://www.nasdaq.com/articles/close-update-stocks-rally-fed-governor-brainard-urges-caution-rate-increases-2016-09-12", "https://www.nasdaq.com/articles/health-care-sector-update-09122016-prgorptphznpcydy-2016-09-12", "https://www.nasdaq.com/articles/horizon-hznp-to-acquire-raptor-for-%24800m-stock-soars-2016-09-13", "https://www.nasdaq.com/articles/mylans-epipen-misclassified-rebates-underpaid-stock-down-2016-09-05", "https://www.nasdaq.com/articles/hznp-crosses-below-key-moving-average-level-2016-09-02", "https://www.nasdaq.com/articles/horizon-hznp-rayos-receives-uspto-notice-of-allowance-2016-08-19", "https://www.nasdaq.com/articles/analysts-see-12-gains-ahead-holdings-iyh-2016-08-18", "https://www.nasdaq.com/articles/top-rated-stock-picks-and-popular-stories-nasdaqcom-august-7-13-2016-08-16", "https://www.nasdaq.com/articles/5-low-price-to-book-stocks-that-can-prove-valuable-2016-08-10", "https://www.nasdaq.com/articles/tuesdays-etf-unusual-volume-vtwo-2016-08-09", "https://www.nasdaq.com/articles/health-care-sector-update-09122016-gern-jnj-rptp-2016-09-12", "https://www.nasdaq.com/articles/mylans-epipen-misclassified-rebates-underpaid-stock-down-2016-09-05", "https://www.nasdaq.com/articles/hznp-crosses-below-key-moving-average-level-2016-09-02", "https://www.nasdaq.com/articles/horizon-hznp-rayos-receives-uspto-notice-of-allowance-2016-08-19", "https://www.nasdaq.com/articles/analysts-see-12-gains-ahead-holdings-iyh-2016-08-18", "https://www.nasdaq.com/articles/top-rated-stock-picks-and-popular-stories-nasdaqcom-august-7-13-2016-08-16", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-8-2016-agn-tsn-hznp-pah-kos-bid-ebix-df-bmch-nat-pgem", "https://www.nasdaq.com/articles/can-horizon-hznp-surprise-earnings-estimates-in-q2-2016-08-04", "https://www.nasdaq.com/articles/horizon-hznp-earnings-up-y-y-keeps-16-view-stock-up-2016-08-09", "https://www.nasdaq.com/articles/horizon-pharma-plc%3A-hznp-stock-pops-after-huge-earnings-beat-2016-08-08", "https://www.nasdaq.com/articles/3-cheap-healthcare-stocks-you-can-buy-right-now-2016-07-21", "https://www.nasdaq.com/articles/looking-for-bargain-stocks-pick-these-5-with-low-p-b-ratio-2016-07-11", "https://www.nasdaq.com/articles/hznp-makes-bullish-cross-above-critical-moving-average-2016-07-07", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-22-using-options-2016-06-30", "https://www.nasdaq.com/articles/horizon-hznp-stock-up-on-ravicti-label-expansion-filing-2016-06-30", "https://www.nasdaq.com/articles/wednesdays-etf-movers-ihe-xlu-2016-06-29", "https://www.nasdaq.com/articles/pre-market-most-active-aug-2-2016-brx-rdsb-drua-armh-idti-nyrt-ftr-cs-cuk-hznp-qqq-xiv", "https://www.nasdaq.com/articles/health-care-sector-update-06012016-hznp-tbph-2016-06-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-xenoport-soars-acquisition-deal-abbvie-crohns-disease-drug-fares", "https://www.nasdaq.com/articles/horizon-hznp-to-buy-global-rights-to-actimmune-stock-down-2016-05-20", "https://www.nasdaq.com/articles/horizon-hznp-stock-up-despite-earnings-revenue-miss-2016-05-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-incyte-juno-therapeutics-halozyme", "https://www.nasdaq.com/articles/horizon-hznp-misses-q1-earnings-and-revenue-estimates-2016-05-09", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-600-follow-through-indicator-80-sensitive", "https://www.nasdaq.com/articles/horizon-pharmas-rebound-sustainable-2016-06-10", "https://www.nasdaq.com/articles/health-care-sector-update-05092016-hznpdepoegrxunis-2016-05-09", "https://www.nasdaq.com/articles/heres-why-horizon-pharma-plcs-stock-slumped-april-2016-05-05", "https://www.nasdaq.com/articles/health-care-sector-update-05052016-hznp-kmph-2016-05-05", "https://www.nasdaq.com/articles/what-caused-depomeds-shares-skyrocket-209-april-2016-05-04", "https://www.nasdaq.com/articles/whats-in-store-for-horizon-hznp-this-earnings-season-2016-05-04", "https://www.nasdaq.com/articles/5-stock-buys-with-impressive-price-to-cash-flow-ratios-2016-04-19", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-iyh-2016-04-15", "https://www.nasdaq.com/articles/close-update-wall-street-posts-mixed-close-oil-weighs-dow-and-health-boosts-nasdaq-2016-05", "https://www.nasdaq.com/articles/health-care-sector-update-05092016-hznpdepoegrxunis-2016-05-09", "https://www.nasdaq.com/articles/heres-why-horizon-pharma-plcs-stock-slumped-april-2016-05-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-advisory-panels-say-yes-intercept-no-clovis-2016-04-13", "https://www.nasdaq.com/articles/why-horizon-pharma-och-ziff-capital-management-and-clovis-oncology-slumped-today-2016-04", "https://www.nasdaq.com/articles/why-one-activist-thinks-company-too-cheap-2016-04-12", "https://www.nasdaq.com/articles/why-horizon-pharma-shares-sank-today-2016-04-12", "https://www.nasdaq.com/articles/why-horizon-pharma-hznp-crashing-today-2016-04-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intercept-clovis-abbvie-relypsa-and-horizon-pharma-2016", "https://www.nasdaq.com/articles/horizon-pharma-plunges-on-bleak-q1-and-1h16-guidance-2016-04-13", "https://www.nasdaq.com/articles/vanguard-total-stock-market-etf-experiences-big-inflow-2016-04-13", "https://www.nasdaq.com/articles/depomed-inc-depo-stock-soars-starboard-stake-2016-04-08", "https://www.nasdaq.com/articles/will-horizon-pharma-hznp-continue-to-surge-higher-2016-04-08", "https://www.nasdaq.com/articles/4-top-ranked-healthcare-stocks-that-surged-last-session-2016-04-07", "https://www.nasdaq.com/articles/raptor-pharmaceutical-stock-upgraded-3-things-you-need-know-2016-04-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-edwards-lifesciences-pra-health-sciences-gilead", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xop-xph-2016-04-12", "https://www.nasdaq.com/articles/3-biotech-stocks-that-make-the-grade-for-investors-2016-03-30", "https://www.nasdaq.com/articles/if-it-wasnt-pfizer-allergan-investors-might-be-getting-pummeled-2016-03-24", "https://www.nasdaq.com/articles/why-valeant-pharmaceuticals-stock-rose-10-tuesday-2016-03-23", "https://www.nasdaq.com/articles/7-best-stocks-under-%2420-that-can-fetch-solid-returns-2016-03-22", "https://www.nasdaq.com/articles/weeks-top-value-picks-hznpcibgxg-2016-03-22", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-down-on-crl-for-kangio-from-fda-2016-03-21", "https://www.nasdaq.com/articles/celgene-pfizer-present-data-from-ulcerative-colitis-trials-2016-03-21", "https://www.nasdaq.com/articles/vti-vis-hznp-bxmt-etf-inflow-alert-2016-04-05", "https://www.nasdaq.com/articles/3-biotech-stocks-that-make-the-grade-for-investors-2016-03-30", "https://www.nasdaq.com/articles/if-it-wasnt-pfizer-allergan-investors-might-be-getting-pummeled-2016-03-24", "https://www.nasdaq.com/articles/why-valeant-pharmaceuticals-stock-rose-10-tuesday-2016-03-23", "https://www.nasdaq.com/articles/spectrum-sppi-incurs-narrower-than-expected-loss-in-q4-2016-03-10", "https://www.nasdaq.com/articles/julian-robertson-buys-8-new-stakes-4th-quarter-2016-03-10", "https://www.nasdaq.com/articles/theravance-tbph-posts-narrower-than-expected-q4-loss-2016-03-10", "https://www.nasdaq.com/articles/aduro-biotech-adro-reports-q4-earnings-revenue-up-2016-03-09", "https://www.nasdaq.com/articles/vti-vis-hznp-bxmt-etf-inflow-alert-2016-03-17", "https://www.nasdaq.com/articles/sanofi-merck-to-dissolve-joint-vaccines-venture-in-europe-2016-03-09", "https://www.nasdaq.com/articles/sanofi-genzyme-present-positive-pompe-disease-study-data-2016-03-04", "https://www.nasdaq.com/articles/astrazenecas-faslodex-gains-fda-nod-for-label-expansion-2016-03-03", "https://www.nasdaq.com/articles/amgen-seeks-fda-approval-for-blincytos-label-expansion-2016-03-02", "https://www.nasdaq.com/articles/company-news-for-march-01-2016-2016-03-01", "https://www.nasdaq.com/articles/juno-juno-posts-line-loss-q4-focus-pipeline-2016-03-01", "https://www.nasdaq.com/articles/horizon-hznp-misses-on-q4-earnings-beats-on-revenues-2016-03-01", "https://www.nasdaq.com/articles/merck-kgaas-q4-earnings-down-y-y-offers-2016-outlook-2016-03-09", "https://www.nasdaq.com/articles/intrexon-xon-reports-wider-q4-loss-beats-on-revenues-2016-03-01", "https://www.nasdaq.com/articles/puma-pbyi-reports-in-line-q4-loss-neratinib-in-focus-2016-03-01", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-shares-are-crashing-today-2016-02-29", "https://www.nasdaq.com/articles/horizon-pharma-misses-on-q4-earnings-beats-on-revenues-2016-02-29", "https://www.nasdaq.com/articles/pre-market-most-active-feb-29-2016-sune-tvix-vrx-fdml-bac-ing-nok-tlk-hznp-xiv-qqq-grpn", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-455-follow-through-indicator-71-sensitive", "https://www.nasdaq.com/articles/endo-endp-tops-q4-earnings-estimates-gives-2016-outlook-2016-02-29", "https://www.nasdaq.com/articles/kite-pharma-q4-loss-wider-focus-remains-kte-c19-2016-03-01", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-29-2016-vrx-endp-iep-nrg-hznp-trco-vgr-acad-grfs-bcpc", "https://www.nasdaq.com/articles/is-horizon-hznp-set-to-disappoint-this-earnings-season-2016-02-26", "https://www.nasdaq.com/articles/jazz-tops-q4-earnings-revenues-up-y-y-gives-2016-view-2016-02-24", "https://www.nasdaq.com/articles/pdl-biopharma-beats-on-q4-earnings-revenues-up-y-y-2016-02-24", "https://www.nasdaq.com/articles/infinity-infi-q4-loss-narrower-than-expected-revenues-lag-2016-02-24", "https://www.nasdaq.com/articles/ariad-incurs-wider-than-expected-loss-in-q4-shares-down-2016-02-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-ing-groep-n.v.-astrazeneca-and", "https://www.nasdaq.com/articles/sareptas-q4-loss-wider-than-expected-eteplirsen-in-focus-2016-02-26", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-29-2016-vrx-endp-iep-nrg-hznp-trco-vgr-acad-grfs-bcpc", "https://www.nasdaq.com/articles/is-horizon-hznp-set-to-disappoint-this-earnings-season-2016-02-26", "https://www.nasdaq.com/articles/jazz-tops-q4-earnings-revenues-up-y-y-gives-2016-view-2016-02-24", "https://www.nasdaq.com/articles/pdl-biopharma-beats-on-q4-earnings-revenues-up-y-y-2016-02-24", "https://www.nasdaq.com/articles/infinity-infi-q4-loss-narrower-than-expected-revenues-lag-2016-02-24", "https://www.nasdaq.com/articles/ariad-incurs-wider-than-expected-loss-in-q4-shares-down-2016-02-24", "https://www.nasdaq.com/articles/clovis-clvs-rociletinib-to-face-fda-advisory-panel-in-april-2016-02-15", "https://www.nasdaq.com/articles/4-stocks-help-combat-brexit-fears-2016-02-23", "https://www.nasdaq.com/articles/repros-fda-meet-to-discuss-issues-of-enclomiphenes-crl-2016-02-09", "https://www.nasdaq.com/articles/amgens-blincyto-and-repatha-positive-in-phase-iii-studies-2016-02-05", "https://www.nasdaq.com/articles/astrazeneca-tops-q4-earnings-falls-on-bleak-2016-outlook-2016-02-05", "https://www.nasdaq.com/articles/glaxo-tops-q4-earnings-revenues-rise-y-y-2016-view-intact-2016-02-04", "https://www.nasdaq.com/articles/sanofi-begins-search-for-vaccine-for-zika-virus-as-fear-grows-2016-02-03", "https://www.nasdaq.com/articles/astrazenecas-lynparza-gets-breakthrough-therapy-status-2016-01-29", "https://www.nasdaq.com/articles/alkermes-initiates-early-stage-study-on-alzheimers-drug-2016-01-27", "https://www.nasdaq.com/articles/cytori-tanks-on-unfavorable-data-from-osteoarthritis-study-2016-02-09", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-horizon-pharma-nxp-semiconductor-and", "https://www.nasdaq.com/articles/oil-short-covering-isnt-share-price-bottom-global-week-ahead-2016-01-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-axiall-trina-solar-deep-value-etf-and", "https://www.nasdaq.com/articles/amgen-presents-encouraging-phase-iii-data-on-vectibix-2016-01-25", "https://www.nasdaq.com/articles/stocks-etfs-below-20-high-returns-2016-01-22", "https://www.nasdaq.com/articles/alkermes-hit-52-week-low-on-unfavorable-phase-iii-data-2016-01-22", "https://www.nasdaq.com/articles/zafgen-soars-on-positive-phase-iii-efficacy-data-on-beloranib-2016-01-21", "https://www.nasdaq.com/articles/3-reasons-horizon-pharma-plcs-stock-could-fall-2016-01-26", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-horizon-pharma-nxp-semiconductor-and", "https://www.nasdaq.com/articles/oil-short-covering-isnt-share-price-bottom-global-week-ahead-2016-01-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-axiall-trina-solar-deep-value-etf-and", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-baxalta-juno-horizon-pharma-abbvie-and-dynavax-2016-01", "https://www.nasdaq.com/articles/health-care-sector-update-01142016-hznp-kpti-2016-01-14", "https://www.nasdaq.com/articles/esperion-espr-initiates-phase-iii-study-for-hyperlipidemia-2016-01-14", "https://www.nasdaq.com/articles/galapagos-glpg-gives-update-on-cystic-fibrosis-program-2016-01-20", "https://www.nasdaq.com/articles/gilead-seeks-approval-for-tenofovir-alafenamide-for-hbv-2016-01-13", "https://www.nasdaq.com/articles/horizon-hznp-ups-view-on-crealta-holdings-deal-shares-up-2016-01-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-aegean-marine-petroleum-network-danaos-tsakos-energy", "https://www.nasdaq.com/articles/alnylam-provides-update-on-rnai-therapeutics-pipeline-2016-01-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-baxalta-shire-combine-jpm-healthcare-conference-focus-2016-01-13", "https://www.nasdaq.com/articles/incyte-incy-provides-update-on-pipeline-candidates-2016-01-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-horizon-pharma-aveo-pharmaceuticals-achillion", "https://www.nasdaq.com/articles/instant-analysis-horizon-pharma-raises-2016-sales-profit-guidance-2016-01-13", "https://www.nasdaq.com/articles/biomarin-reveals-interim-data-from-pompe-disease-study-2016-01-12", "https://www.nasdaq.com/articles/5-smart-piigs-stocks-buy-now-2016-01-12", "https://www.nasdaq.com/articles/abbvie-starts-phase-iii-program-on-abt-494-for-ra-treatment-2016-01-11", "https://www.nasdaq.com/articles/abbvies-viekira-pak-snda-accepted-with-priority-review-2016-01-08", "https://www.nasdaq.com/articles/vicals-vl-2397-gets-orphan-status-for-invasive-aspergillosis-2016-01-07", "https://www.nasdaq.com/articles/peregrine-pphm-inks-research-partnership-for-bavituximab-2016-01-07", "https://www.nasdaq.com/articles/conatus-cnat-reports-positive-phase-ii-data-on-emricasan-2016-01-07", "https://www.nasdaq.com/articles/surmodics-buys-normedix-for-%2414m-adjusts-2016-outlook-2016-01-12", "https://www.nasdaq.com/articles/gilead-up-on-encouraging-data-on-tenofovir-alafenamide-2016-01-06", "https://www.nasdaq.com/articles/teva-active-biotech-halt-high-doses-of-laquinimod-for-ms-2016-01-05", "https://www.nasdaq.com/articles/pfizer-merck-kgaa-partner-with-syndax-for-ovarian-cancer-2016-01-05", "https://www.nasdaq.com/articles/these-3-industries-could-die-2016-2016-01-04", "https://www.nasdaq.com/articles/bristol-myers-opdivo-yervoy-sbla-to-face-final-decision-2016-01-04", "https://www.nasdaq.com/articles/alkermes-upgraded-to-hold-on-encouraging-portfolio-update-2016-01-04", "https://www.nasdaq.com/articles/epizyme-initiates-dosing-in-phase-ii-study-on-tazemetostat-2015-12-31", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-shares-jumped-68-2015-2016-01-06", "https://www.nasdaq.com/articles/discovery-laboratories-advances-respiratory-disease-drug-2015-12-30", "https://www.nasdaq.com/articles/anika-anik-starts-enrolment-in-phase-iii-hyalofast-study-2015-12-30", "https://www.nasdaq.com/articles/chimerix-cmrx-tanks-on-disappointing-brincidofovir-data-2015-12-29", "https://www.nasdaq.com/articles/kamada-kmda-reports-encouraging-data-on-rabies-drug-2015-12-29", "https://www.nasdaq.com/articles/weeks-top-value-stocks-hznp-df-2015-12-29", "https://www.nasdaq.com/articles/gw-pharmaceuticals-publishes-encouraging-epidiolex-data-2015-12-28", "https://www.nasdaq.com/articles/adamas-adms-surges-on-positive-data-on-lead-candidate-2015-12-24", "https://www.nasdaq.com/articles/dr.-reddys-rdy-relaunches-generic-nexium-in-the-u.s.-2015-12-31", "https://www.nasdaq.com/articles/discovery-laboratories-advances-respiratory-disease-drug-2015-12-30", "https://www.nasdaq.com/articles/zacks.com-featured-expert-kevin-matras-highlights%3A-silicon-motion-technology-orbotech", "https://www.nasdaq.com/articles/xbiotechs-xbit-cancer-drug-meets-endpoint-shares-up-2015-12-08", "https://www.nasdaq.com/articles/peg-ratio-vs-pe-ratio-2015-12-08", "https://www.nasdaq.com/articles/epizyme-updates-non-hodgkin-lymphoma-drug-trial-data-2015-12-08", "https://www.nasdaq.com/articles/health-care-sector-update-12012015-hznp-xtnt-ormp-2015-12-01", "https://www.nasdaq.com/articles/horizons-hznp-ravicti-okd-in-eu-for-urea-cycle-disorders-2015-12-01", "https://www.nasdaq.com/articles/aveo-licenses-tivozanib-european-rights-to-eusa-pharma-2015-12-22", "https://www.nasdaq.com/articles/horizon-hznp-to-acquire-crealta-holdings-in-a-%24510m-deal-2015-12-14", "https://www.nasdaq.com/articles/zacks.com-featured-expert-kevin-matras-highlights%3A-silicon-motion-technology-orbotech", "https://www.nasdaq.com/articles/xbiotechs-xbit-cancer-drug-meets-endpoint-shares-up-2015-12-08", "https://www.nasdaq.com/articles/latest-specialty-pharmacy-opportunity-profit-2015-11-11", "https://www.nasdaq.com/articles/pre-market-most-active-nov-11-2015-smfg-jcp-hznp-lyg-m-caj-baba-aapl-qqq-xlnx-tvix-fb-2015", "https://www.nasdaq.com/articles/why-horizon-pharma-crashing-today-2015-11-11", "https://www.nasdaq.com/articles/strength-seen-in-horizon-pharma-hznp%3A-stock-jumps-6.1-2015-11-10", "https://www.nasdaq.com/articles/can-horizon-pharma-hznp-run-higher-on-strong-earnings-estimate-revisions-2015-11-30", "https://www.nasdaq.com/articles/us-stock-futures-higher-healthcare-rebound-nike-buyback-2015-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-11202015-hznp-siro-vrx-2015-11-20", "https://www.nasdaq.com/articles/horizon-hznp-slips-comments-on-express-scripts-charges-2015-11-12", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-6-2015-ci-bam-hum-aee-tcp-hznp-tph-aby-sats-ssp-viv", "https://www.nasdaq.com/articles/horizon-hznp%3A-whats-in-store-this-earnings-season-2015-11-04", "https://www.nasdaq.com/articles/3-stocks-buy-now-biotech-2015-11-02", "https://www.nasdaq.com/articles/horizon-pharmas-stock-briefly-spikes-investor-update-2015-11-09", "https://www.nasdaq.com/articles/heres-why-horizon-pharma-plc-soaring-today-2015-10-23", "https://www.nasdaq.com/articles/fridays-etf-movers-xph-xrt-2015-10-23", "https://www.nasdaq.com/articles/interesting-hznp-put-and-call-options-december-18th-2015-10-21", "https://www.nasdaq.com/articles/horizon-pharma-now-oversold-hznp-2015-10-20", "https://www.nasdaq.com/articles/tuesdays-etf-movers-gdxj-xph-2015-10-20", "https://www.nasdaq.com/articles/tuesday-sector-laggards-drugs-biotechnology-stocks-2015-10-20", "https://www.nasdaq.com/articles/january-2018-options-now-available-horizon-pharma-hznp-2015-10-12", "https://www.nasdaq.com/articles/mondays-etf-movers-ihe-gdx-2015-10-26", "https://www.nasdaq.com/articles/3-biotech-stocks-have-been-unfairly-beaten-down-2015-10-06", "https://www.nasdaq.com/articles/health-care-sector-update-10022015-hznp-hls-clrb-2015-10-02", "https://www.nasdaq.com/articles/interesting-hznp-put-and-call-options-may-2016-2015-09-28", "https://www.nasdaq.com/articles/how-bulls-are-playing-horizon-2015-09-24", "https://www.nasdaq.com/articles/horizon-pharma-now-oversold-hznp-2015-09-24", "https://www.nasdaq.com/articles/horizon-pharma-hznp-in-focus%3A-stock-plunges-12-2015-09-23", "https://www.nasdaq.com/articles/health-care-sector-update-09222015-stj-vblt-hznp-2015-09-22", "https://www.nasdaq.com/articles/4-biotech-stocks-now-bargain-prices-2015-10-09", "https://www.nasdaq.com/articles/use-options-chance-buy-hznp-52-discount-2015-09-18", "https://www.nasdaq.com/articles/bulls-returning-horizon-pharma-2015-09-18", "https://www.nasdaq.com/articles/health-care-sector-update-09022015-mrk-ghdx-hznp-2015-09-02", "https://www.nasdaq.com/articles/first-week-october-16th-options-trading-horizon-pharma-hznp-2015-08-28", "https://www.nasdaq.com/articles/health-care-sector-update-08272015-tbio-rdhl-hznp-2015-08-27", "https://www.nasdaq.com/articles/call-buyers-come-back-horizon-2015-08-26", "https://www.nasdaq.com/articles/use-options-chance-buy-hznp-53-discount-2015-08-18", "https://www.nasdaq.com/articles/horizon-pharma-hznp-shares-cross-below-200-dma-2015-09-22", "https://www.nasdaq.com/articles/health-care-sector-update-08132015-hznp-achn-2015-08-13", "https://www.nasdaq.com/articles/company-news-for-august-10-2015-corporate-summary-2015-08-10", "https://www.nasdaq.com/articles/horizon-pharma-hznp-q2-earnings-up-y-y-revenues-beat-tale-of-the-tape-2015-08-07", "https://www.nasdaq.com/articles/whats-behind-depomeds-soaring-share-price-july-2015-08-06", "https://www.nasdaq.com/articles/horizon-pharma-hznp%3A-whats-in-store-in-q2-earnings-analyst-blog-2015-08-05", "https://www.nasdaq.com/articles/horizon-pharma-up-on-expected-q2-sales-2015-outlook-analyst-blog-2015-07-21", "https://www.nasdaq.com/articles/health-care-sector-update-07202015-hznpexelcrmd-2015-07-20", "https://www.nasdaq.com/articles/horizon-pharma-gets-vote-confidence-2015-08-18", "https://www.nasdaq.com/articles/horizons-hostile-bid-depomed-too-low-2015-07-09", "https://www.nasdaq.com/articles/midday-update-sp-500-breaches-200-day-support-greece-continuing-pressure-global-markets", "https://www.nasdaq.com/articles/why-shares-depomed-inc-are-charging-35-higher-2015-07-07", "https://www.nasdaq.com/articles/pre-market-most-active-jul-7-2015-oln-dcm-bhp-hznp-fit-san-siri-xiv-bp-qqq-aapl-tvix-2015", "https://www.nasdaq.com/articles/close-update-wall-street-reverses-course-technical-support-holds-greek-deal-hopes-kept", "https://www.nasdaq.com/articles/health-care-sector-update-07072015-esprdepohznpetrm-2015-07-07", "https://www.nasdaq.com/articles/health-care-sector-update-07072015-depohznppbmdetrm-2015-07-07", "https://www.nasdaq.com/articles/bulls-rolling-horizon-pharma-2015-07-17", "https://www.nasdaq.com/articles/5-healthy-stocks-top-biotech-etf-etf-news-and-commentary-2015-06-17", "https://www.nasdaq.com/articles/horizon-pharma-hnzp-starts-phase-iii-study-on-actimmune-analyst-blog-2015-06-08", "https://www.nasdaq.com/articles/bulls-come-back-horizon-pharma-2015-06-02", "https://www.nasdaq.com/articles/use-options-chance-buy-hznp-46-discount-2015-05-21", "https://www.nasdaq.com/articles/actavis-tops-1q-earnings-wide-margin-provides-outlook-analyst-blog-2015-05-11", "https://www.nasdaq.com/articles/endo-endp-beats-on-q1-earnings-2015-guidance-upped-analyst-blog-2015-05-11", "https://www.nasdaq.com/articles/merrimack-pharmaceuticals-q1-loss-wider-than-expected-analyst-blog-2015-05-08", "https://www.nasdaq.com/articles/3-moneymaking-biotech-stocks-consider-buying-2015-07-05", "https://www.nasdaq.com/articles/horizon-pharma-hznp-misses-earnings-upped-view-tale-of-the-tape-2015-05-08", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-300-follow-through-indicator-54-sensitive", "https://www.nasdaq.com/articles/emergent-biosolutions-ebs-loss-wider-than-expectations-analyst-blog-2015-05-08", "https://www.nasdaq.com/articles/health-care-sector-update-05072015-aveo-achn-hznp-2015-05-07", "https://www.nasdaq.com/articles/pre-market-earnings-report-may-8-2015-hcn-nrg-wwav-br-nrf-lvnta-siro-vet-hznp-lmca-cst-aol", "https://www.nasdaq.com/articles/whats-in-store-for-horizon-pharma-hznp-in-q1-earnings-analyst-blog-2015-05-07", "https://www.nasdaq.com/articles/regeneron-beats-on-q1-earnings-eylea-2015-view-upped-analyst-blog-2015-05-07", "https://www.nasdaq.com/articles/pre-market-most-active-may-8-2015-alu-nok-smlp-qqq-baba-xiv-eric-aapl-gsk-syt-nvda-hznp", "https://www.nasdaq.com/articles/genomic-health-q1-loss-wider-than-expected-revenues-lag-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/prothena-prta-posts-narrower-than-expected-loss-in-q1-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/trovagene-trov-q1-loss-wider-than-expected-shares-plunge-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/3-biotech-stocks-news-2015-05-05", "https://www.nasdaq.com/articles/aegerions-q1-loss-narrower-than-expected-view-retained-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/zoetis-beats-on-q1-earnings-revenue-guidance-lowered-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/keryx-biopharmaceuticals-posts-in-line-loss-revenue-beat-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/myriad-genetics-posts-in-line-q3-earnings-guides-lower-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/genomic-health-q1-loss-wider-than-expected-revenues-lag-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/prothena-prta-posts-narrower-than-expected-loss-in-q1-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/novo-nordisk-nvo-beats-on-q1-earnings-updates-outlook-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/momentas-q1-loss-narrower-than-expected-revenues-miss-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-reports-in-line-earnings-ups-view-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/bristol-myers-supplemental-bla-for-opdivo-accepted-by-fda-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/amerisourcebergen-corp-beats-on-q2-earnings-ups-view-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/seattle-genetics-posts-narrower-than-expected-loss-in-q1-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/sanofis-sny-basal-insulin-toujeo-gains-european-approval-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/celladons-advanced-heart-failure-study-fails-shares-crash-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/will-horizon-pharma-hznp-continue-to-surge-higher-tale-of-the-tape-2015-04-27", "https://www.nasdaq.com/articles/eli-lillys-cyramza-gains-fda-approval-for-label-expansion-analyst-blog-2015-04-27", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-releases-data-on-lead-drug-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/notable-option-activity-equities-2015-04-23", "https://www.nasdaq.com/articles/alexion-misses-q1-earnings-estimates-keeps-2015-outlook-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/united-therapeutics-falls-on-q1-loss-misses-on-revenues-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/emergent-biosolutions-resumes-biothrax-manufacturing-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/actelion-aliof-beats-q1-earnings-revenue-expectations-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/pfizers-cancer-drug-meets-first-primary-endpoint-in-phase-iii-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/the-medicines-co.s-new-minocin-formulation-approved-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-under-review-for-new-indication-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/merck-kgaa-pfizer-start-first-cancer-registration-study-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/mercks-keytruda-tops-melanoma-lung-cancer-studies-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/acorda-reports-encouraging-data-on-ms-drug-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-surging-higher-year-2015-04-18", "https://www.nasdaq.com/articles/use-options-chance-buy-hznp-47-discount-2015-04-17", "https://www.nasdaq.com/articles/pre-market-most-active-apr-17-2015-nok-cnhi-akba-xiv-ge-alu-qqq-sne-bac-aapl-fb-hznp-2015", "https://www.nasdaq.com/articles/actelion-to-boost-progress-of-specialty-immunology-pipeline-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-for-chronic-heart-failure-drug-corlanor-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/health-care-sector-update-04162015-acad-rcpt-hznp-2015-04-16", "https://www.nasdaq.com/articles/pre-market-most-active-apr-16-2015-nok-alu-cnhi-c-sndk-bhp-tsm-hznp-nflx-xiv-cplp-qqq-2015", "https://www.nasdaq.com/articles/oncomed-down-on-phase-ib-lung-cancer-study-data-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-surging-higher-year-2015-04-18", "https://www.nasdaq.com/articles/horizon-pharmas-actimmune-gets-fast-track-status-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/novo-nordisks-tresiba-ryzodeg-ndas-under-fda-review-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/mercks-hcv-combo-drug-gets-two-breakthrough-status-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-caterpillar-procter-gamble-horizon-pharma-radnet-and", "https://www.nasdaq.com/articles/clovis-oncologys-rucaparib-gets-breakthrough-status-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/the-medicines-co.s-kengreal-backed-for-fda-approval-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/pre-market-most-active-apr-15-2015-nok-alu-bac-stwd-kep-intc-eric-bhp-fomx-qqq-aapl-hznp", "https://www.nasdaq.com/articles/aeterna-zentaris-to-advance-hormone-drug-to-phase-iii-study-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/horizon-pharmas-actimmune-gets-fast-track-status-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-hyperion-therapeutics-conatus-amgen-and", "https://www.nasdaq.com/articles/repros-secondary-hypogonadism-drug-under-fda-review-analyst-blog-2015-04-02", "https://www.nasdaq.com/articles/dyaxs-hereditary-angioedema-drug-meets-primary-endpoint-analyst-blog-2015-04-01", "https://www.nasdaq.com/articles/sarepta-ceo-exits-eteplirsen-regulatory-filing-on-track-analyst-blog-2015-04-01", "https://www.nasdaq.com/articles/3-top-small-cap-growth-stocks-building-momentum-now-stocks-news-2015-04-07", "https://www.nasdaq.com/articles/horizon-pharma-to-buy-hyperion-therapeutics-for-%241.1b-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/strength-seen-in-horizon-pharma-hznp%3A-stock-rises-18.2-tale-of-the-tape-2015-03-31", "https://www.nasdaq.com/articles/amgens-kyprolis-gets-fda-priority-review-for-expanded-use-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/midday-update-stocks-rally-ma-deals-chinas-new-silk-road-bullish-home-sales-2015-03-30", "https://www.nasdaq.com/articles/notable-option-activity-equities-2015-03-30", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-soaring-today-2015-03-30", "https://www.nasdaq.com/articles/dreamworks-scores-big-home-2015-03-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-horizon-buy-hyperion-conatus-liver-disease-data-analyst-blog-2015-04", "https://www.nasdaq.com/articles/us-stock-futures-gain-data-health-care-deals-dominate-2015-03-30", "https://www.nasdaq.com/articles/calls-win-big-horizon-pharma-2015-03-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-newlink-genetic-and-llumina-press", "https://www.nasdaq.com/articles/novo-nordisk-to-submit-interim-devote-data-to-the-fda-analyst-blog-2015-03-27", "https://www.nasdaq.com/articles/momentum-bulls-stick-horizon-2015-03-26", "https://www.nasdaq.com/articles/novo-nordisks-onset-1-onset-2-meet-primary-objectives-analyst-blog-2015-03-26", "https://www.nasdaq.com/articles/heat-biologics-posts-wider-loss-y-y-focus-on-pipeline-analyst-blog-2015-03-30", "https://www.nasdaq.com/articles/lpath-lptn-crumbles-on-failure-of-kidney-cancer-drug-trial-analyst-blog-2015-03-25", "https://www.nasdaq.com/articles/3-excellent-biotech-stocks-buy-dip-stocks-news-2015-03-25", "https://www.nasdaq.com/articles/isis-pharmaceuticals-reports-phase-i-data-on-lipid-candidate-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/vertex-falls-on-disappointing-kalydecovx-661-combo-data-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/novo-nordisks-saxenda-gets-eu-approval-for-obesity-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/amicus-to-seek-for-migalastats-approval-in-the-u.s.-eu-analyst-blog-2015-03-20", "https://www.nasdaq.com/articles/eli-lilly-collaborates-with-korean-hanmi-pharmaceutical-analyst-blog-2015-03-20", "https://www.nasdaq.com/articles/regenerons-eylea-gets-fda-approval-for-label-expansion-analyst-blog-2015-03-26", "https://www.nasdaq.com/articles/kite-pharma-kite-acquires-t-cell-factory-focus-on-europe-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/actelions-uptravi-shows-long-term-benefit-in-griphon-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/mercks-sugammadex-faces-setback-fda-delays-meeting-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/syntas-q4-loss-narrows-y-y-focus-on-lung-cancer-drug-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/emergent-biosolutions-morphosys-start-cancer-drug-study-analyst-blog-2015-03-10", "https://www.nasdaq.com/articles/strength-seen-in-horizon-pharma-hznp%3A-stock-rises-5.1-tale-of-the-tape-2015-03-09", "https://www.nasdaq.com/articles/osiris-therapeutics-q4-earnings-down-y-y-revenues-soar-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/lexicon-ipsen-agreement-expanded-to-include-canada-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/health-care-sector-update-03062015-cala-isis-hznp-2015-03-06", "https://www.nasdaq.com/articles/bristol-myers-oncology-drug-opdivo-label-expanded-in-u.s.-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/merck-inks-deal-with-eisai-for-cancer-combo-therapy-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/can-the-rally-in-horizon-pharma-hznp-shares-continue-tale-of-the-tape-2015-03-04", "https://www.nasdaq.com/articles/orexigen-soars-as-interim-data-on-contrave-comes-to-light-analyst-blog-2015-03-04", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-up-on-u.s.-approval-of-xyrem-rems-analyst-blog-2015-03-04", "https://www.nasdaq.com/articles/arena-pharmaceuticals-q4-loss-wider-than-expected-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/emergent-biosolutions-lags-earnings-cancels-2015-view-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/bristol-myers-files-for-new-indications-for-yervoy-opdivo-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/horizon-pharma-beats-on-q4-earnings-lifts-2015-guidance-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/health-care-sector-update-02272015-pcyc-hznp-bvx-2015-02-27", "https://www.nasdaq.com/articles/pre-market-most-active-feb-27-2015-rovi-tot-jcp-blmn-bac-hmc-pbr-fcau-tvix-aapl-clne-hznp", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-27-2015-iep-nrg-isis-hpt-xls-nrf-cst-rdc-kbr-ptct-pnm", "https://www.nasdaq.com/articles/why-horizon-pharma-plc-stock-skyrocketed-today-2015-02-20", "https://www.nasdaq.com/articles/will-ariad-aria-impress-on-iclusig-sales-this-earnings-analyst-blog-2015-02-18", "https://www.nasdaq.com/articles/amgen-celimmune-tie-up-for-autoimmune-disorder-drug-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/health-care-sector-update-12262014-nvs-hznp-act-2014-12-26", "https://www.nasdaq.com/articles/cheap-stocks-2015-best-buys-healthcare-2014-12-10", "https://www.nasdaq.com/articles/sector-update-health-care-2014-11-06-0", "https://www.nasdaq.com/articles/sector-update-health-stocks-generally-flat-pre-bell-2014-11-06", "https://www.nasdaq.com/articles/will-horizon-pharma-hznp-earnings-surprise-this-season-analyst-blog-2014-11-05", "https://www.nasdaq.com/articles/sector-update-health-stocks-higher-pre-bell-2014-10-17", "https://www.nasdaq.com/articles/sector-update-health-care-2014-10-17-0", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-16-using-options-2015-01-29", "https://www.nasdaq.com/articles/sector-update-smaller-rise-health-care-stocks-today-horizon-pharma-turns-lower-despite", "https://www.nasdaq.com/articles/horizon-pharmas-actimmune-gets-orphan-drug-designation-analyst-blog-2014-10-07", "https://www.nasdaq.com/articles/3-best-performing-stocks-september-analyst-blog-2014-10-01", "https://www.nasdaq.com/articles/nasdaq-biotechnology-top-performers-market-open-september-11-2014-09-11", "https://www.nasdaq.com/articles/will-horizon-pharma-hznp-earnings-miss-estimates-in-q2-analyst-blog-2014-08-06", "https://www.nasdaq.com/articles/pre-market-most-active-jul-28-2014-fdo-dltr-acrx-hznp-trla-loco-sny-dg-bhp-gsk-fb-aapl", "https://www.nasdaq.com/articles/monday-sector-laggards-metals-fabrication-products-drugs-2014-07-28", "https://www.nasdaq.com/articles/sector-update-health-care-2014-10-14-0", "https://www.nasdaq.com/articles/salix-pharmaceuticals-surges-on-positive-ibs-data-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/amgen-gets-breakthrough-therapy-status-for-leukemia-drug-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/mondays-etf-movers-gdxj-ibb-2014-06-23", "https://www.nasdaq.com/articles/horizon-pharma-hznp-stock-has-huge-short-interest%3A-time-to-cover-tale-of-the-tape-2014-06", "https://www.nasdaq.com/articles/horizon-pharma-hznp%3A-an-off-the-radar-potential-winner-tale-of-the-tape-2014-05-29", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-higher-horizon-pharma-9-q1-results-2014-05-09", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-09-0", "https://www.nasdaq.com/articles/companys-first-profit-can-mean-big-profits-investors-screen-week-2014-07-08", "https://www.nasdaq.com/articles/horizon-pharma-hznp-sees-hammer-chart-pattern%3A-time-to-buy-tale-of-the-tape-2014-05-01", "https://www.nasdaq.com/articles/commit-buy-horizon-pharma-10-earn-191-annualized-using-options-2014-04-07", "https://www.nasdaq.com/articles/is-a-short-squeeze-ahead-for-horizon-pharma-hznp-tale-of-the-tape-2014-03-25", "https://www.nasdaq.com/articles/roundtable-top-picks-for-the-week-of-mar.-24th-video-blog-2014-03-24", "https://www.nasdaq.com/articles/horizon-pharma-to-buy-vidara-shares-rise-analyst-blog-2014-03-20", "https://www.nasdaq.com/articles/healthcare-stocks-crawling-higher-horizon-pharma-shares-jump-over-14-after-deal-vidara", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-19-0", "https://www.nasdaq.com/articles/earnings-reaction-history-horizon-pharma-inc-143-follow-through-indicator-67-sensitive", "https://www.nasdaq.com/articles/us-futures-barely-higher-ahead-fed-statement-2014-03-19", "https://www.nasdaq.com/articles/pre-market-most-active-mar-19-2014-vz-rdsa-hznp-orcl-qqq-nok-sny-fcel-kndi-gern-siri-bp", "https://www.nasdaq.com/articles/after-hours-most-active-mar-19-2014-btu-jpm-qqq-wfc-bpo-stag-met-gild-hznp-adsk-csco-msft", "https://www.nasdaq.com/articles/horizon-pharma-hznp-jumps%3A-stock-rises-5.6-tale-of-the-tape-2014-03-18", "https://www.nasdaq.com/articles/horizon-pharma-banks-two-one-arthritis-drugs-2014-03-14", "https://www.nasdaq.com/articles/sector-update-health-care-2014-03-13", "https://www.nasdaq.com/articles/sector-update-health-care-shares-mixed-pre-market-progenics-3-smaller-expected-q4-loss", "https://www.nasdaq.com/articles/us-futures-slightly-higher-ahead-yellens-first-fomc-presser-oracle-misses-views-2014-03-19", "https://www.nasdaq.com/articles/should-you-worry-about-the-short-interest-in-horizon-pharma-hznp-tale-of-the-tape-2014-02", "https://www.nasdaq.com/articles/horizon-pharma-hznp-shares-march-higher-can-it-continue-tale-of-the-tape-2014-02-21", "https://www.nasdaq.com/articles/horizon-pharma-hznp-catches-eye%3A-stock-soars-18.2-tale-of-the-tape-2014-01-30", "https://www.nasdaq.com/articles/affymetrixs-revenue-guidance-tops-ests-analyst-blog-2014-01-08", "https://www.nasdaq.com/articles/patients-enrolled-in-synageva-study-analyst-blog-2014-01-07", "https://www.nasdaq.com/articles/after-hours-most-active-dec-19-2013-bac-csco-qqq-pky-msft-ms-hznp-jpm-ge-hsbc-atvi-mu-2013", "https://www.nasdaq.com/articles/insider-trading-blackstone-sells-majority-seaworld-shares-2013-12-18", "https://www.nasdaq.com/articles/biopharms-wont-buy-farm-investment-ideas-2014-02-27", "https://www.nasdaq.com/articles/horizon-pharma-inc-hznp-enters-overbought-territory-tale-of-the-tape-2013-09-18", "https://www.nasdaq.com/articles/actavis-in-patent-infringement-case-analyst-blog-2013-08-28", "https://www.nasdaq.com/articles/horizon-pharma-settles-with-par-pharma-analyst-blog-2013-08-26", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-progenix-narrows-q2-net-loss-2013-08-09", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-09-1", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-18-2013-kior-imos-nmrx-ta-hwcc-insm-amrc-ptx-strl-hznp", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-10-2012-bam-jcp-har-cyd-hsft-cldx-hznp-scr-xin-urre-hska", "https://www.nasdaq.com/articles/pre-market-most-active-nov-19-2013-exxi-nct-alu-aeg-bbva-bby-hsbc-hznp-tsla-fb-vod-slm", "https://www.nasdaq.com/articles/earnings-preview%3A-covidien-analyst-blog-2012-07-23", "https://www.nasdaq.com/articles/covidien-teams-up-with-horizon-analyst-blog-2012-06-19", "https://www.nasdaq.com/articles/new-pfizer-6-drug-companies-bullish-short-trends-2011-12-15", "https://www.nasdaq.com/articles/mixed-3q-for-covidien-profit-drops-analyst-blog-2012-07-26"], "Content": []}